TW201137037A - Liquid crystal-aligning agent, liquid crystal alignment film, and liquid crystal display element using same - Google Patents

Liquid crystal-aligning agent, liquid crystal alignment film, and liquid crystal display element using same Download PDF

Info

Publication number
TW201137037A
TW201137037A TW099145804A TW99145804A TW201137037A TW 201137037 A TW201137037 A TW 201137037A TW 099145804 A TW099145804 A TW 099145804A TW 99145804 A TW99145804 A TW 99145804A TW 201137037 A TW201137037 A TW 201137037A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
formula
group
polyimine
Prior art date
Application number
TW099145804A
Other languages
Chinese (zh)
Other versions
TWI494374B (en
Inventor
Kazuyoshi Hosaka
Hiroshi Kita
Masaaki Katayama
Koji Sonoyama
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201137037A publication Critical patent/TW201137037A/en
Application granted granted Critical
Publication of TWI494374B publication Critical patent/TWI494374B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/50Physical properties
    • C08G2261/53Physical properties liquid-crystalline

Abstract

A liquid crystal-aligning agent comprising at least one kind of a polymer selected from the group consisting of a polyamic acid, which is obtained by reacting a diamine component containing a diamine compound represented by formula [1] with a tetracarboxylic dianhydride, and a polyimide obtained by the dewatering cyclization of said polyamic acid. In formula [1], X1 represents -O-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH2O-, -COO-, -OCO-, -CON(CH3)- or -N(CH3)CO-; X2 represents a single bond or an aliphatic hydrocarbon group, a non-aromatic cyclic hydrocarbon group or an aromatic hydrocarbon group, each group having 1 to 20 carbon atoms; X3 represents a single bond, -O-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -COO-, -OCO-, -CON(CH3)-, -N(CH3)CO- or -O(CH2)m- (wherein m is an integer of 1 to 5); X4 represents an organic group having 1 to 20 carbon atoms; and n is an integer of 1 to 4.

Description

201137037 六、發明說明 【發明所屬之技術領域】 本發明係有關一種液晶顯示元件所使用的液晶配向處 理劑、液晶配向膜及液晶顯示元件。 【先前技術】 於液晶顯示元件中,液晶配向膜具有使液晶朝一定方 向配向的效果。現在,在工業上所利用的主要液晶配向 膜’係將聚醯亞胺前驅體之聚醯胺酸(亦稱爲聚醯胺酸)或 由聚醯亞胺溶液所成的聚醯亞胺系液晶配向處理劑塗佈於 基板上予以成膜、製作。而且,對基板面而言,使液晶平 行配向或傾斜配向時,於成膜後再藉由摩擦處理進行表面 延伸處理。而且,亦提案藉由利用偏光紫外線照射等之異 向性光化學反應的方法以取代摩擦處理,近年來朝向工業 化進行檢討。 液晶配向膜係爲進行控制對基板之液晶的角度、即液 晶之預傾角時使用,惟使液晶顯示元件予以高性能化,其 利用範圍逐年擴大中,不僅是可得一定的預傾角,且預傾 角之安定性亦變得日益重要。 就預傾角之安定性而言,於液晶配向膜之製造工程 中’以不視摩擦條件而定可得一定預傾角爲目的時,提案 在聚釀亞胺系液晶配向處理劑中含有於分子內具有· 2個以^ 上之環氧基的化合物(例如參照專利文獻〗)。 而且,於液晶顯示元件之製造工程中,爲提高'液晶之 -5- 201137037 配向均勻性時,於封入液晶後,進行加熱處理’使液晶予 以均向化。然而,預傾角之安定性低時,於該均向性處理 後,無法得到目的大小之預傾角,或引起預傾角產生不均 句的問題。特別是爲得高亮度時,使用發熱量大的背景光 之液晶顯示元件,或在汽車用途中所使用的液晶顯示元 件、例如導航器、或儀表板,會有在高溫環境下長時間使 用或放置的情形。於該過於嚴苛的條件下,預傾角慢慢產 生變化時,無法得到初期的顯示特性或於顯示時產生斑紋 等之問題。 近年來,廣泛地實用於大畫面、高精細的液晶電視, 該液晶顯示元件與主要以顯示文字或靜止影像之銀幕用途 的液晶顯示元件相比時,被要求在過於嚴苛的使用環境下 長時間忍耐使用的特性。因此,液晶配向膜要求更高的信 賴性。特別是電特性之一的電壓保持率降低時,會有容易 引起液晶顯示元件之顯示不佳的線燒成的情形,無法得到 信賴性高的液晶顯示元件。因此,不僅要求初期特性佳, 且例如即使於高溫下長時間曝曬後,仍不易有降低的情 形。 [習知技術文獻] [專利文獻] 專利文獻1 :日本特開平7 -2 3 44 1 0號公報 【發明內容】 本發明係有鑑於上述情形者,其課題係提供一種即使 -6- 201137037 長時間在高溫環境下,預傾角之安定性優異且可抑制電壓 保持率降低的液晶配向膜,具有該液晶配向膜之液晶顯示 元件’及形成該液晶配向膜用之液晶配向處理劑。 本發明人等再三深入硏究檢討的結果,發現使用特定 的二胺化合物作爲二胺成分之聚醯胺酸及/或使該聚醯胺 酸予以醯亞胺所得的含有聚醯亞胺之液晶配向處理劑,爲 達成上述目的時極爲有效,遂而完成本發明。而且,上述 特定的二胺化合物,含有文獻中未有記載的要旨者。 換言之,本發明係具有下述之要旨者。 [1 ] 一種液晶配向處理劑,其特徵爲含有選自由使以 式[1 ]所示之含二胺化合物的二胺成分與四羧酸二酐反應 所得的聚醯胺酸,及使該聚醯胺酸進行脫水閉環所得的聚 醯亞胺所成群中至少1種的聚合物。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element used in a liquid crystal display element. [Prior Art] In the liquid crystal display device, the liquid crystal alignment film has an effect of aligning the liquid crystals in a certain direction. Nowadays, the main liquid crystal alignment film used in the industry is a polyamido acid (also known as polylysine) or a polyamidene solution formed from a polyimine solution. The liquid crystal alignment treatment agent is applied onto a substrate to form a film. Further, when the liquid crystal is aligned in the direction of the substrate or obliquely aligned, the surface of the substrate is subjected to surface stretching treatment by rubbing treatment. Further, it has been proposed to use a method of anisotropic photochemical reaction such as polarized ultraviolet ray irradiation instead of rubbing treatment, and in recent years, it has been reviewed for industrialization. The liquid crystal alignment film is used for controlling the angle of the liquid crystal to the substrate, that is, the pretilt angle of the liquid crystal. However, the liquid crystal display element is improved in performance, and the use range thereof is expanding year by year, and not only a certain pretilt angle but also a pretilt angle can be obtained. The stability of the dip is also becoming increasingly important. In terms of the stability of the pretilt angle, in the manufacturing process of the liquid crystal alignment film, it is proposed to contain a predetermined pretilt angle regardless of the friction condition, and it is proposed to be contained in the molecule in the polyaniline liquid crystal alignment treatment agent. A compound having two epoxy groups (for example, see Patent Document). Further, in the manufacturing process of the liquid crystal display device, in order to improve the uniformity of the alignment of the liquid crystal, the liquid crystal is sealed after the liquid crystal is sealed, and the liquid crystal is made uniform. However, when the stability of the pretilt angle is low, after the uniformity treatment, the pretilt angle of the target size cannot be obtained, or the problem that the pretilt angle causes an uneven sentence is caused. In particular, in the case of high brightness, a liquid crystal display element using a background light having a large amount of heat, or a liquid crystal display element used in an automobile application, such as a navigator or an instrument panel, may be used for a long time in a high temperature environment or Placement situation. Under such severe conditions, when the pretilt angle is slowly changed, the initial display characteristics or the occurrence of streaks during display cannot be obtained. In recent years, it has been widely used in large-screen, high-definition liquid crystal televisions, which are required to be used in an overly harsh environment when compared with liquid crystal display elements that are mainly used for displaying screen characters or still images. Time to endure the characteristics of use. Therefore, liquid crystal alignment films require higher reliability. In particular, when the voltage holding ratio of one of the electrical characteristics is lowered, there is a case where the display of the liquid crystal display element is likely to be poor, and the liquid crystal display element having high reliability cannot be obtained. Therefore, not only the initial characteristics are required to be good, but also, for example, even after exposure to a high temperature for a long period of time, it is not easy to have a reduced shape. [PRIOR ART DOCUMENT] [Patent Document 1] Japanese Patent Laid-Open No. Hei. No. 7-2, No. 3, No. 4, No. A liquid crystal alignment film having excellent stability of a pretilt angle and suppressing a decrease in voltage holding ratio in a high-temperature environment, a liquid crystal display element having the liquid crystal alignment film, and a liquid crystal alignment treatment agent for forming the liquid crystal alignment film. The inventors of the present invention have further intensively reviewed the results of the review and found that the polyamine containing the specific diamine compound as the diamine component and/or the polyimine-containing liquid crystal obtained by subjecting the polyamic acid to the imine. The alignment treatment agent is extremely effective in achieving the above object, and the present invention has been completed. Further, the above specific diamine compound contains those not described in the literature. In other words, the present invention has the following gist. [1] A liquid crystal alignment treatment agent comprising a polyamic acid selected from the group consisting of a diamine component containing a diamine compound represented by the formula [1] and a tetracarboxylic dianhydride, and the polymerization is carried out. At least one polymer of a group of polyimine obtained by dehydration ring closure of proline.

(式[1]中,Χι 係-0-、-NH-、-N(CH3)-、-CONH-、-NHCO-(In the formula [1], Χι is -0-, -NH-, -N(CH3)-, -CONH-, -NHCO-

x2係單鍵、碳數1〜20之脂肪族烴基、非芳香族環式烴 基、或芳香族烴基,X3係單鍵、-0-、-NH-、-N(CH3)-、X2 is a single bond, an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group, or an aromatic hydrocarbon group, and a X3 single bond, -0-, -NH-, -N(CH3)-,

-N(CH3)CO-或- 0(CH2)m-(m係1〜5之整數),X4係表示碳 數1〜20之有機基,n係1〜4之整數) 201137037 (2) 如上述[1 ]記載之液晶配向處理劑,其中式[丨]之 x2係單鍵或碳數1〜5之伸烷莛。 (3) 如上述[1]或(2)記載之液晶配向處理劑,其中式 [1]之X4係碳數1〜5之烷基。 (4) 如上述[1]〜(3)中任一項記載之液晶配向處理 劑,其中式[1]中之X,係-0-、-CONH -或- COO-,X3係單 鍵或- Ο-,η係1 » (5) 如上述[1]〜(4)中任一項記載之液晶配向處理 劑,其中二胺成分中之5〜80莫耳%爲以式[1 ]所示之二胺 化合物。 (6) —種液晶配向膜,其特徵爲使用上述[1]〜(5)中 任一項記載之液晶配向處理劑所得者。 (7) —種液晶顯示元件,其特徵爲具有上述(6)記載 之液晶配向膜。 (8) —種二胺化合物,其特徵爲以下述式[1]所示。 [化2]-N(CH3)CO- or - 0(CH2)m- (m is an integer of 1 to 5), X4 represents an organic group having 1 to 20 carbon atoms, and n is an integer of 1 to 4) 201137037 (2) The liquid crystal alignment treatment agent according to the above [1], wherein x2 of the formula [丨] is a single bond or an alkylene group having a carbon number of 1 to 5. (3) The liquid crystal alignment treatment agent according to the above [1], wherein X4 of the formula [1] is an alkyl group having 1 to 5 carbon atoms. (4) The liquid crystal alignment treatment agent according to any one of the above-mentioned [1], wherein X in the formula [1] is -0-, -CONH- or -COO-, X3 is a single bond or In the liquid crystal alignment treatment agent according to any one of the above [1] to (4), wherein 5 to 80 mol% of the diamine component is in the formula [1] A diamine compound is shown. (6) A liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent according to any one of the above [1] to (5). (7) A liquid crystal display element comprising the liquid crystal alignment film according to (6) above. (8) A diamine compound characterized by the following formula [1]. [Chemical 2]

[1] (式[1]中,Xi /^-〇-、-NH-、-N(CH3)-、-CONH-、-NHCO- 、-ch2o-、-coo-、-oco-、-con(ch3)-或-n(ch3)co-, X2係單鍵、碳數1〜20之脂肪族烴基、非芳香族環式烴 基、或芳香族烴基,X3係單鍵、-〇-、-NH-、-N(CH3)-、 -C0NH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-、 201137037 -N(CH3)CO-或- CKCHOn^m係1〜5之整數),X4係表示碳 數1〜20之有機基,η係1〜4之整數) (9) 一種聚醯亞胺,其特徵爲使含有上述(8)記載之 以式Π]所示之二胺化合物的二胺成分與四羧酸二酐反應 所得的聚醯胺酸或使該聚醯胺酸脫水閉環所得者。 [發明效果] 由本發明之液晶配向處理劑所得的液晶配向膜,即使 長時間在高溫環境下,預傾角之安定性優異,且可抑制電 壓保持率降低。因此,具有該液晶配向膜之液晶顯示元件 的信賴性優異。 而且,藉由本發明,可提高作爲液晶配向處理劑等之 原料的有用的新穎二胺化合物。 [爲實施發明之形態] 本發明之液晶配向處理劑,係使用下述式[1 ]所示之 具有氧雜環丁烷基之二胺化合物(以下亦稱爲特定二胺化 合物)。 [化3][1] (in the formula [1], Xi /^-〇-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -ch2o-, -coo-, -oco-, -con (ch3)- or -n(ch3)co-, X2 single bond, aliphatic hydrocarbon group having 1 to 20 carbon atoms, non-aromatic cyclic hydrocarbon group, or aromatic hydrocarbon group, X3 single bond, -〇-, - NH-, -N(CH3)-, -C0NH-, -NHCO-, -COO-, -OCO-, -CON(CH3)-, 201137037 -N(CH3)CO- or - CKCHOn^m system 1~5 (Integer), X4 represents an organic group having 1 to 20 carbon atoms, and an integer of η is 1 to 4) (9) A polyimine which is characterized by containing the formula (8) The polyamine acid obtained by reacting the diamine component of the diamine compound with the tetracarboxylic dianhydride or the polyhydric acid is dehydrated and closed. [Effect of the Invention] The liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is excellent in the stability of the pretilt angle even in a high temperature environment for a long period of time, and can suppress a decrease in the voltage holding ratio. Therefore, the liquid crystal display element having the liquid crystal alignment film is excellent in reliability. Moreover, according to the present invention, a useful novel diamine compound which is a raw material of a liquid crystal alignment treatment agent or the like can be improved. [In order to carry out the invention] The liquid crystal alignment agent of the present invention is a diamine compound having an oxetanyl group (hereinafter also referred to as a specific diamine compound) represented by the following formula [1]. [Chemical 3]

[1] (式[1]中,乂1係-0-、-]^1€-、-:^((:113)-、-(:0]^11-、-]^11(:0-、-CH20-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-, 201137037 x2係單鍵、碳數1〜2 0之脂肪族烴基、非芳香族環式烴 基 '或芳香族烴基,Χ3係單鍵、-0-、-ΝΗ-、-N(CH3)-、 -CONH-、-NHCO-、-COO-、-0C0-、-CON(CH3)-、 -N(CH3)CO-或-0(CH2)m-(m係1〜5之整數),X4係表示 碳數1〜20之有機基,η係1〜4之整數) 於本發明中,藉由使含有特定的二胺化合物之二胺成 分與四羧酸二酐反應所得的聚醯胺酸,及使該聚醯胺酸進 行脫水閉環所得的聚醯亞胺,亦總稱爲聚合物。使用本發 明之特定二胺化合物所得的聚合物,具有下述式(1 a)之側 鏈。 [化4] —XfX2_X3[1] (In the formula [1], 乂1 series-0-, -]^1€-, -:^((:113)-, -(:0]^11-, -]^11(:0 -, -CH20-, -COO-, -OCO-, -CON(CH3)- or -N(CH3)CO-, 201137037 x2 is a single bond, an aliphatic hydrocarbon group having a carbon number of 1 to 2 0, a non-aromatic ring a hydrocarbon group or an aromatic hydrocarbon group, a Χ3 series single bond, -0-, -ΝΗ-, -N(CH3)-, -CONH-, -NHCO-, -COO-, -0C0-, -CON(CH3)- -N(CH3)CO- or -0(CH2)m- (m is an integer of 1 to 5), X4 represents an organic group having 1 to 20 carbon atoms, and an integer of η is 1 to 4). In the present invention a polylysine obtained by reacting a diamine component containing a specific diamine compound with a tetracarboxylic dianhydride, and a polyimine obtained by subjecting the polyamic acid to dehydration ring closure, also collectively referred to as a polymer The polymer obtained by using the specific diamine compound of the present invention has a side chain of the following formula (1a). [Chemical 4] - XfX2_X3

[la] (式(la)中,Xi、X2、X3及X4係與上述式[1]之定義相同 的意義) 存在於式(la)之側鏈的端部之氧雜環丁烷基,在加熱 下與羧基及/或羥基反應。另外’ 2個氧雜環丁烷基亦可互 相加成聚合。藉由此等之反應形成複數個聚合物交聯的構 造。由於氧雜環丁烷基較環氧基之求核性更高’故反應效 率高。因此,具有式(la)之側鏈的複數個聚合物更爲容易 交聯,更容易形成交聯密度高的構造之液晶配向膜。另 外,由於氧雜環丁烷基爲4碳環構造’與錢基及/或經基 進行反應時’與具有3碳環構造之環氧基相比時’在鍵結 部位上含有多於1個之亞甲基。此外’由於存在於式(la) -10- 201137037 之側鏈的端部之氧雜環丁烷基,容易製得交聯密度高的構 造,同時具有拉伸性或韌性高的性質之液晶配向膜。藉此 推測,於摩擦時變得不易阻害聚合物之延伸性,不易引起 擦傷或割傷情形。 另外,存在於式(la)之側鏈的端部之氧雜環丁烷基, 可有效地進行交聯反應,藉此,於添加交聯性化合物時, 不會有導致液晶顯示元件特性降低等原因之未反應的交聯 性化合物殘留的情形。 藉由上述,由本發明之液晶配向處理劑所得的液晶配 向膜’與不具交聯性化合物之液晶配向膜或添加有交聯性 化合物之液晶配向膜相比時,可提高預傾角對熱之安定 性’且在高溫環境下可抑制電壓保持率降低的情形。因 此,由於不易產生顯示不佳之一的線燒成情形,故可製得 信賴性優異的液晶顯示元件。 <特定二胺化合物> 本發明之特定二胺化合物’係下述式[1 ]所示之具有 氧雜環丁烷基的二胺化合物。 [化5][la] (in the formula (la), Xi, X2, X3 and X4 have the same meanings as defined in the above formula [1]) oxetanyl group present at the end of the side chain of the formula (la), It reacts with a carboxyl group and/or a hydroxyl group under heating. Further, the two oxetanyl groups may be added to each other to form a polymerization. By this reaction, a plurality of polymer crosslinked structures are formed. Since the oxetane group has higher nuclearity than the epoxy group, the reaction efficiency is high. Therefore, a plurality of polymers having a side chain of the formula (la) are more easily crosslinked, and it is easier to form a liquid crystal alignment film having a high crosslinking density. In addition, since the oxetanyl group is a 4-carbon ring structure, when reacting with a thiol group and/or a thiol group, 'when compared with an epoxy group having a 3-carbon ring structure, 'containing more than 1 at a bonding site. Methylene group. Further, 'the oxetane group which is present at the end of the side chain of the formula (la)-10-201137037, it is easy to obtain a structure having a high crosslinking density and a liquid crystal alignment having high tensile properties or toughness. membrane. From this, it is presumed that it becomes difficult to prevent the elongation of the polymer during rubbing, and it is less likely to cause scratches or cuts. Further, the oxetane group which is present at the end of the side chain of the formula (la) can effectively carry out the crosslinking reaction, whereby the crosslinking property is not caused to cause deterioration of the characteristics of the liquid crystal display element. The case where the unreacted crosslinkable compound remains for the same reason. According to the above, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention can improve the pretilt angle to heat stability when compared with a liquid crystal alignment film having no crosslinkable compound or a liquid crystal alignment film to which a crosslinkable compound is added. Sexuality and suppression of a decrease in voltage holding ratio in a high temperature environment. Therefore, since the wire firing of one of the poor display is less likely to occur, a liquid crystal display element having excellent reliability can be obtained. <Specific Diamine Compound> The specific diamine compound of the present invention is a diamine compound having an oxetane group represented by the following formula [1]. [Chemical 5]

式[1]中 ’ X,係選自-0-、-NH-、-N(CH3)-、-CONH-' X in the formula [1] is selected from -0-, -NH-, -N(CH3)-, -CONH-

-11 - 201137037 -N(CH3)CO-之 2 價有機基。其中’-O-'-NH-'-CONH-、-NHCO-、-CON(CH3)-、-CH20·、-COO-或-OCO-,就容 易合成二胺化合物較佳。更佳者爲- Ο-、-CON Η-、 -CON(CH3)-' -CH20-或-COO-。尤佳者爲-〇-、-CONH-或 -COO- 〇最佳者爲-COO — 式[1]中,x2係單鍵、碳數1〜20之脂肪族烴基、非 芳香族環式烴基或芳香族烴基。 碳數1〜20之脂肪族烴基,可以爲直鏈狀,亦可爲支 鏈狀。另外,亦可具有不飽和鍵。 非芳香族烴基之具體例,如環丙烷環、環丁烷環、環 戊烷環、環己烷環、環庚烷環、環辛烷環、環壬烷環、環 癸烷環、環十一烷環、環十二烷環、環十三烷環、環十四 烷環、環十五烷環、環十六烷環 '環十七烷環、環十八烷 環、環十九烷環、環二十烷環、三環二十烷環、三環二十 二烷環、二環庚烷環、脫氫萘環、正冰片烯環、金鋼烷環 等。 芳香族烴基之具體例,如苯環、萘環、四氫萘環、莫 環、茚環、芴環、蒽環、菲環、葩(phenalene)環等。 較佳的X2爲單鍵、碳數1〜1〇之伸烷基、碳數1〜 10之不飽和伸烷基、環丙烷環、環丁烷環、環戊烷環、 環己烷環、環庚烷環、正冰片烯環、金鋼烷環、苯環、萘 環、四氫萘環、芴環或蒽環,更佳者爲單鍵 '碳數1〜1() 之院基、碳數1〜10之不飽和院基、環己院環、正冰片稀 環、金鋼烷環、苯環、萘環、芴環或蒽環,尤佳者爲單 -12- 201137037 鍵、碳數1〜5之伸烷基或苯環。最佳者爲單鍵或碳數1 〜5之伸烷基。 式[1]中,X3 係選自單鍵、-0-、-NH-、-N(CH3)-、 -CONH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-、 -N(CH3)CO-或-0(CH2)m-(m係1〜5之整數)。較佳者爲選 自單鍵、-Ο-、-NH-、-CONH-、-NHCO-、-COO-、-OCO-、或- 0(CH2)m-(m係1〜5之整數),更佳者爲單鍵、-〇-、-NH-、-CONH-、-NHCO-、-COO-、-OCO -或- 0(CH2)m-(m係1〜5之整數),尤佳者爲單鍵、-〇-、-CONH-或 -COO-,最佳者爲單鍵或-0-。 式[1]中,X4係表示碳數1〜20之有機基,於該有機 基中亦可含有雜原子(N、0、S、Si)。較佳者爲碳數1〜 10之烷基,更佳者爲碳數1〜5之烷基。 式[1]中,η爲1〜4之整數。就與四羧酸二酐之反應 性而言,較佳者爲1〜3,以1更佳。 式[1]之二個胺基(-ΝΗ2)之鍵結位置,沒有特別的限 制。具體而言,對側鏈之鍵結基(X 〇而言,苯環上之2、3 之位置、2、4之位置、2、5之位置、2、6之位置、3、4 之位置、3、5之位置。其中,就使聚醯胺酸合成時之反 應性而言,以2、4之位置、2、5之位置或3、5之位置 較佳。就使二胺化合物合成時之容易性而言,以2、4之 位置或3、5之位置更佳。 式[1]之 乂1爲-〇-、-C0NH-或- COO-,Χ3 爲單鍵或- 〇- ’ η爲1更佳。 -13- 201137037 而且’式[1]之X,爲-0-、-CONH-或- COO-,X2爲單 鍵或碳數1〜5之伸烷基,X3爲單鍵或- 0-,X4爲碳數1 〜5之烷基,!1爲1最佳。 式[1]之X1、X2、X3、X4及η之較佳組合,如下述表 1所示。 [表1]-11 - 201137037 -N(CH3)CO- 2 valent organic base. Among them, '-O-'-NH-'-CONH-, -NHCO-, -CON(CH3)-, -CH20., -COO- or -OCO- is preferred because it is easy to synthesize a diamine compound. More preferred are - Ο-, -CON Η-, -CON(CH3)-'-CH20- or -COO-. Particularly preferred is -〇-, -CONH- or -COO- 〇 is preferably -COO - in the formula [1], x2 is a single bond, an aliphatic hydrocarbon group having a carbon number of 1 to 20, and a non-aromatic cyclic hydrocarbon group. Or an aromatic hydrocarbon group. The aliphatic hydrocarbon group having 1 to 20 carbon atoms may be linear or branched. In addition, it may have an unsaturated bond. Specific examples of the non-aromatic hydrocarbon group, such as a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a cyclooctane ring, a cyclodecane ring, a cyclodecane ring, and a ring Monoalkane, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring 'cyclohexadecane ring, cyclooctadecane ring, cyclopentadecane Ring, cycloecosane ring, tricyclohexadecane ring, tricyclotetracosane ring, bicycloheptane ring, dehydronaphthalene ring, norbornene ring, gold steel ring, and the like. Specific examples of the aromatic hydrocarbon group include a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, a molybdenum ring, an anthracene ring, an anthracene ring, an anthracene ring, a phenanthrene ring, a phenalene ring and the like. Desirable X2 is a single bond, an alkylene group having 1 to 1 carbon atom, an unsaturated alkyl group having 1 to 10 carbon atoms, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a norbornene ring, a gold alkyl alkane ring, a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an anthracene ring or an anthracene ring, and more preferably a single bond 'carbon number 1 to 1 () Unsaturated polycarbonate with a carbon number of 1 to 10, ring of cyclohexyl ring, thin ring of ortho-azide, alkane ring of gold, benzene ring, naphthalene ring, anthracene ring or anthracene ring, especially preferred is single-12-201137037 bond, carbon A number 1 to 5 alkyl or benzene ring. The most preferred ones are single bonds or alkylene groups having a carbon number of 1 to 5. In the formula [1], X3 is selected from the group consisting of a single bond, -0-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -COO-, -OCO-, -CON(CH3)- -N(CH3)CO- or -0(CH2)m- (m is an integer from 1 to 5). Preferably, it is selected from the group consisting of a single bond, -Ο-, -NH-, -CONH-, -NHCO-, -COO-, -OCO-, or -0(CH2)m- (m is an integer of 1 to 5) More preferably, it is a single bond, -〇-, -NH-, -CONH-, -NHCO-, -COO-, -OCO- or -0(CH2)m- (m is an integer of 1 to 5), especially The best one is a single bond, -〇-, -CONH- or -COO-, and the best one is a single bond or -0-. In the formula [1], X4 represents an organic group having 1 to 20 carbon atoms, and may also contain a hetero atom (N, 0, S, Si) in the organic group. Preferred is an alkyl group having 1 to 10 carbon atoms, more preferably an alkyl group having 1 to 5 carbon atoms. In the formula [1], η is an integer of 1 to 4. In terms of reactivity with tetracarboxylic dianhydride, it is preferably from 1 to 3, more preferably from 1. The bonding position of the two amine groups (-ΝΗ2) of the formula [1] is not particularly limited. Specifically, the bonding group of the side chain (X 〇, the position of 2, 3 on the benzene ring, the position of 2, 4, the position of 2, 5, the position of 2, 6, the position of 3, 4) In the position of 3, 5, in terms of the reactivity in the synthesis of polylysine, the position of 2, 4, 2, 5 or 3, 5 is preferred. In terms of easiness of time, it is better to position 2 or 4 or 3 or 5. The 乂1 of the formula [1] is -〇-, -C0NH- or -COO-, Χ3 is a single bond or - 〇- ' η is 1 is better. -13- 201137037 and X of the formula [1] is -0-, -CONH- or -COO-, X2 is a single bond or an alkylene group having a carbon number of 1 to 5, and X3 is A single bond or -0-, X4 is an alkyl group having a carbon number of 1 to 5, and !1 is preferably 1. A preferred combination of X1, X2, X3, X4 and η of the formula [1] is shown in Table 1 below. . [Table 1]

Xi X, x3 X* η A- 1 -0- 單鍵 單鍵 碳數1〜5之院基 1 Α- 2 碳數卜5之伸烷基 單鍵 碳數1〜5之烷基 1 Α- 3 -0- 碳數卜5之伸烷基 *〇- 碳數1〜5之烷基 - 1 A — 4 -C0NH- 單鍵 單鍵 碳數卜5之烷基 1 A — 5 -C0NH- 碳數1〜5之伸烷基 單鍵 碳數1〜5之院基 1 A- 6 -C0NH- 碳數卜5之伸烷基 碳數1〜5之烷基 1 A- 7 -COO- 單鍵 單鍵 碳數1〜5之院基 1 A- 8 - COO- 碳數1〜5之伸烷基 單鍵 碳數1〜5之烷基 1 A- 9 -coo- 碳數1〜5夕伸焼基 碳數1〜5之烷基 1 <特定二胺化合物之合成方法> 製造以本發明之式[1]所示之特定二胺化合物之方 法,沒有特別的限制,較佳的方法例如下述之方法。 本發明之特定二胺化合物,可藉由合成以下述式(2) 所示之二硝基體,再使硝基還原,變換成胺基而製得。 [化6]Xi X, x3 X* η A- 1 -0- single bond single bond carbon number 1~5 of the yard base 1 Α- 2 carbon number b 5 alkyl group single bond carbon number 1~5 alkyl 1 Α- 3 -0- Carbon number 5 alkyl group * 〇 - alkyl group having 1 to 5 carbon atoms - 1 A - 4 -C0NH- single bond single bond carbon number 5 alkyl group 1 A - 5 -C0NH- carbon Number of 1 to 5 alkyl groups having a single bond carbon number of 1 to 5 1 A- 6 -C0NH- carbon number 5 alkyl group having 1 to 5 alkyl groups 1 A- 7 -COO- single bond Single bond carbon number 1~5 of yard base 1 A- 8 - COO- carbon number 1~5 alkyl group single bond carbon number 1~5 alkyl 1 A- 9 -coo- carbon number 1~5 Alkyl group 1 having a thiol group number of 1 to 5 <Synthesis method of a specific diamine compound> A method for producing a specific diamine compound represented by the formula [1] of the present invention is not particularly limited, and a preferred method For example, the method described below. The specific diamine compound of the present invention can be obtained by synthesizing a dinitro group represented by the following formula (2), reducing the nitro group, and converting it into an amine group. [Chemical 6]

(式(2)之 Χ2、Χ3、χ4 及 η 係與式[1]之 X,、Χ2、Χ3、 Χ4及η之定義相同) 使二硝基還原的方法,沒有特別的限制,通常使用 -14 - 201137037 鈀-碳、氧化鉑、雷氏鎳、鉑黑、铑-氧化鋁、硫化鉑碳等 作爲觸媒,在醋酸乙酯、甲苯、四氫呋喃、二噁烷、醇系 溶劑等之溶劑中,藉由氫氣、聯胺、氯化氫等進行的方 法。 式(2)之二硝基體對二硝基苯而言,可藉由經由X!, 使-x2-x3鍵結的方法等製得。(Χ2, Χ3, χ4, and η of the formula (2) are the same as the definitions of X, Χ2, Χ3, Χ4, and η of the formula [1]) The method for reducing the dinitro group is not particularly limited, and is usually used - 14 - 201137037 Palladium-carbon, platinum oxide, nickel-plated nickel, platinum black, lanthanum-alumina, sulphide-platinum carbon, etc. as a catalyst, in a solvent such as ethyl acetate, toluene, tetrahydrofuran, dioxane or an alcohol solvent A method carried out by hydrogen, hydrazine, hydrogen chloride or the like. The dinitrobenzene of the formula (2) can be produced by a method of bonding -x2-x3 via X!, for dinitrobenzene.

Xi係選自-〇-(醚鍵)、-NH-(胺鍵)、-N(CH3)-(甲基化 胺基鍵)' -CONH-(醯胺鍵)、-NHCO-(逆醯胺鍵)、-CH20-(亞甲基醚鍵)、-COO-(酯鍵)、-OCO-(逆酯鍵)、 -CON(CH3)-(N-甲基化醯胺鍵)及-N(CH3)CO-(N-甲基化逆 醯胺鍵)之鍵結基,此等之鍵結基可以一般的有機合成方 法形成。 例如X!爲醚或甲二醚鍵時,使對應的含二硝基之鹵 素衍生物與含有x2、x3及x4之羥基衍生物,在鹼存在下 進行反應的方法,或使含二硝基之羥基衍生物與含有具 X2、X3及X4之氧雜環丁烷基的鹵素取代衍生物,在鹼存 在下進行反應的方法。 爲胺鍵時,例如使對應的含二硝基之鹵素衍生物與含 有具X2、X3及X4之氧雜環丁烷基的鹵素取代衍生物,在 鹼存在下進行反應的方法。 爲醯胺鍵時,例如使對應的含硝基之酸氯化物與含有 具x2、x3及x4之氧雜環丁烷基的胺基取代衍生物,在鹼 存在下進行反應的方法。 爲逆醯胺鍵時,例如使對應的含硝基之胺基取代物與 -15- 201137037 含有具x2、x3及χ4之氧雜環丁烷基的酸氯化物,在鹼存 在下進行反應的方法。 爲酯鍵時,例如使對應的含硝基之酸氯化物與含有具 X2、x3及X4之氧雜環丁烷基的羥基取代衍生物,在鹼存 在下進行反應的方法。 爲逆酯鍵時,例如使對應的含硝基之羥基衍生物與含 有具x2、x3及x4之氧雜環丁烷基的酸氯化物,在鹼存在 下進行反應的方法。 含二硝基之鹵素衍生物及含二硝基之衍生物的具體 例,如3,5-二硝基氯苯、2,4-二硝基氯苯、2,4-二硝基氟 苯、3,5-二硝基苯甲酸氯化物、3,5·二硝基苯甲酸、2,4-二硝基苯甲酸氯化物、2,4·二硝基苯甲酸、3,5-二硝基苯 甲基氯化物、2,4-二硝基苯甲基氯化物、3,5-二硝基苯甲 醇、2,4-二硝基苯甲醇、2,4-二硝基苯胺' 3,5·二硝基苯 胺、2,6-二硝基苯胺、2,4-二硝基苯酚、2,5-二硝基苯 酚、2,6-二硝基苯酚、2,4-二硝基苯基醋酸等。就考慮原 料之取得性、反應而言,可選擇使用一種或複數種。 <其他二胺化合物> 於本發明中,在不會損害本發明之效果內,可倂用特 定二胺化合物外之其他的二胺化合物作爲二胺成分。其具 體例如下所述。 p-苯二胺、2,3,5,6-四甲基-P-苯二胺、2,5-二甲基-P-苯二胺、m-苯二胺、2,4 -二甲基-m-苯二胺、2,5-二胺基甲 -16- 201137037 苯、2,6-二胺基甲苯、2,5-二胺基苯酚、2,4-二胺基苯 酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯 甲醇、4,6-二胺基間苯二酚、4,4’-二胺基聯苯、3,3’-二甲 基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、 3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二羧基-4,4’-二胺基 聯苯、3,3’-二氟-4,4’-聯苯、3,3’-三氟化甲基-4,4’-二胺 基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺 基聯苯、2,3’-二胺基聯苯、4,4’-二胺基苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺 基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二 苯醚、3,3’ -二胺基二苯醚、3,4’ -二胺基二苯醚、2,2’ -二 胺基二苯醚、2,3’-二胺基二苯醚、4,4’-磺醯基二苯胺、 3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基) 矽烷、二甲基-雙(4-胺基苯基)矽烷、二甲基雙(3-胺基苯 基)矽烷、4,4’-硫化二苯胺、3,3’-硫化二苯胺、4,4’-二胺 基二苯胺、3,3’-二胺基二苯胺、3,4’-二胺基二苯胺、 2,2’-二胺基二苯胺' 2,3’-二胺基二苯胺、N-甲基(4,4、二 胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基 (3,4’_二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、 N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、 3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基 萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二 胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、 2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基 -17- 201137037 萘、1,2-雙(4-胺基苯基)乙烷、i,2-雙(3-胺基苯基)乙烷、 1,3-雙(4-胺基苯基)丙烷、1,3-雙(3·胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4_雙(4-胺基苯基)苯、1,3-雙(4-胺 基苯基)苯、1,4-雙(4-胺基苯甲基)苯' 1,3-雙(4-胺基苯氧 基)苯、4,4’-[1,4-亞苯基雙(亞甲基)]二苯胺、4,4’-[1,3-亞 苯基雙(亞甲基)]二苯胺、3,4’-[1,4-亞苯基雙(亞甲基)]二 苯胺、3,4’-[1,3·亞苯基雙(亞甲基)]二苯胺、3,3’-[1,4-亞 苯基雙(亞甲基)]二苯胺、3,3’-[1,3-亞苯基雙(亞甲基)]二 苯胺、1,4-亞苯基雙[(4-胺基苯基)甲酮]、1,4-亞苯基雙 [(3-胺基苯基)甲酮]、1,3-亞苯基雙[(4-胺基苯基)甲酮]、 1,3-亞苯基雙[(3-胺基苯基)甲酮]、1,4-亞苯基雙(4-胺基 苯甲酸酯)、1,4·亞苯基雙(3-胺基苯甲酸酯)、1,3-亞苯基 雙(4-胺基苯甲酸酯)、1,3-亞苯基雙(3-胺基苯甲酸酯)、雙 (4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸 酯、雙(4-胺基苯基)異苯二甲酸酯、雙(3-胺基苯基)異苯 二甲酸酯、Ν,Ν’-(1,4-亞苯基)雙(4-胺基苯并醯胺)、Ν,Ν’-(1,3-亞苯基)雙(4-胺基苯并醯胺)、Ν,Ν’-(1,4-亞苯基)雙 (3-胺基苯并醯胺)、Ν,Ν’-(1,3-亞苯基)雙(3-胺基苯并醯 胺)、Ν,Ν’-雙(4-胺基苯基)對酞醯胺、Ν,Ν’-雙(3-胺基苯 基)對酞醯胺、Ν,Ν’-雙(4-胺基苯基)異酞醯胺、Ν,Ν’-雙 (3-胺基苯基)異酞醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙 (4-胺基苯氧基)二苯基颯、2,2’-雙[4-(4-胺基苯氧基)苯基] -18 - 201137037 丙烷、2,2’-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2’_雙 (4_胺基苯基)六氟丙烷2,2’-雙(3-胺基苯基)六氟丙烷、 2,2’ -雙(3-胺基_4_甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯 基)丙烷、2,2,-雙(3-胺基苯基)丙烷、2,2,_雙(3_胺基_4_甲 基苯基)丙烷、3,5-二胺基苯甲酸、2,5_二胺基苯甲酸、 1,3-雙(4-胺基苯氧基)丙院、l,3-雙(3-胺基苯氧基)丙垸、 1,4-雙(4-胺基苯氧基)丁烷、l,4-雙(3-胺基苯氧基)丁烷、 1,5-雙(4-胺基苯氧基)戊烷、i,5-雙(3-胺基苯氧基)戊烷、 16 -雙(4-胺基苯氧基)己烷、i,6 -雙(3 -胺基苯氧基)己烷、 1,7_雙(4 -胺基苯氧基)庚院、l,7-(3 -胺基苯氧基)庚垸、 1,8-雙(4-胺基苯氧基)辛烷、1,8_雙(3_胺基苯氧基)辛烷、 1,9-雙(4_胺基苯氧基)壬烷、ι,9-雙(3·胺基苯氧基)壬烷、 M〇-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、 111-(1胺基苯氧基)十一烷、1,11-(3-胺基苯氧基)十一 院、1,12-(4 -胺基苯氧基)十二烷、1;12-(3 -胺基苯氧基)十 二烷等之芳香族二胺、雙(4-胺基環己基)甲烷、雙(4-胺 基-3-甲基環己基)甲烷等之脂環式二胺、1,3-二胺基丙 院' 1,4-二胺基丁烷、i,5-二胺基戊烷、1,6-二胺基己 院、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬 烷、1,10-二胺基癸烷、1,11-二胺基十一烷、1,12-二胺基 十二烷等之脂肪族二胺。 此外,例如在二胺側鏈上具有烷基、含氟之烷基、芳 香環、脂肪族環、雜環或由此等所成的大環狀取代物之二 胺’具體而言例如以下述式[DA1]〜式[DA32]所示之二 -19- 201137037 胺。 [化7]Xi is selected from the group consisting of -〇-(ether bond), -NH-(amine bond), -N(CH3)-(methylated amine bond)'-CONH-(melamine bond), -NHCO-(reverse 醯Amine bond), -CH20- (methylene ether bond), -COO- (ester bond), -OCO- (reverse ester bond), -CON(CH3)-(N-methylated guanamine bond) and - A bonding group of N(CH3)CO-(N-methylated reverse guanamine bond), which can be formed by a general organic synthesis method. For example, when X! is an ether or a methylenediether bond, a corresponding dinitro-containing halogen derivative and a hydroxy derivative containing x2, x3 and x4 are reacted in the presence of a base, or a dinitro group is contained. A method in which a hydroxy derivative and a halogen-substituted derivative having an oxetanyl group having X2, X3 and X4 are reacted in the presence of a base. In the case of an amine bond, for example, a method in which a corresponding dinitro group-containing halogen derivative and a halogen-substituted derivative containing an oxetanyl group having X2, X3 and X4 are reacted in the presence of a base. In the case of a guanamine bond, for example, a method in which a corresponding nitro acid chloride is contained and an amino group-substituted derivative having an oxetanyl group having x2, x3 and x4 is reacted in the presence of a base. In the case of a reverse amide bond, for example, the corresponding nitro group-containing amine substituent and -15-201137037 containing an acid chloride having x2, x3 and χ4 oxetanyl groups are reacted in the presence of a base. method. In the case of an ester bond, for example, a method in which a corresponding nitro acid chloride is contained and a hydroxy-substituted derivative containing an oxetanyl group having X2, x3 and X4 is reacted in the presence of a base. In the case of a reverse ester bond, for example, a method in which a corresponding nitro group-containing hydroxy derivative and an acid chloride having an oxetanyl group having x2, x3 and x4 are reacted in the presence of a base. Specific examples of dinitro-containing halogen derivatives and dinitro-containing derivatives, such as 3,5-dinitrochlorobenzene, 2,4-dinitrochlorobenzene, 2,4-dinitrofluorobenzene , 3,5-dinitrobenzoic acid chloride, 3,5·dinitrobenzoic acid, 2,4-dinitrobenzoic acid chloride, 2,4·dinitrobenzoic acid, 3,5-di Nitrobenzyl chloride, 2,4-dinitrobenzyl chloride, 3,5-dinitrobenzyl alcohol, 2,4-dinitrobenzyl alcohol, 2,4-dinitroaniline 3,5·dinitroaniline, 2,6-dinitroaniline, 2,4-dinitrophenol, 2,5-dinitrophenol, 2,6-dinitrophenol, 2,4-di Nitrophenylacetic acid and the like. One or a plurality of species may be selected in consideration of the availability and reaction of the raw materials. <Other diamine compound> In the present invention, other diamine compounds other than the specific diamine compound may be used as the diamine component without impairing the effects of the present invention. The specifics thereof are as follows. P-phenylenediamine, 2,3,5,6-tetramethyl-P-phenylenediamine, 2,5-dimethyl-P-phenylenediamine, m-phenylenediamine, 2,4-dimethicone Base-m-phenylenediamine, 2,5-diaminomethyl-16-201137037 Benzene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3 ,5-Diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, 4,4'-diaminobiphenyl , 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy- 4,4'-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'-biphenyl, 3,3' -Trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl , 2,3'-diaminobiphenyl, 4,4'-diaminophenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'-Diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-di Diphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, two Methyl-bis(4-aminophenyl)decane, dimethylbis(3-aminophenyl)decane, 4,4'-sulfurized diphenylamine, 3,3'-sulfurized diphenylamine, 4,4' -diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine' 2,3'-diaminodiphenylamine , N-methyl (4,4, diaminodiphenyl)amine, N-methyl (3,3'-diaminodiphenyl)amine, N-methyl (3,4'-diamine Diphenyl)amine, N-methyl(2,2'-diaminodiphenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4,4'- Diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diamine Benzophenone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8- Diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diamino-7-201137037 naphthalene, 1,2- (4-Aminophenyl)ethane, i,2-bis(3-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,3-double (3· Aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4) -aminophenyl)methane, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-amino group Phenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene' 1,3-bis(4-aminophenoxy) Benzene, 4,4'-[1,4-phenylenebis(methylene)]diphenylamine, 4,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3, 4'-[1,4-phenylenebis(methylene)]diphenylamine, 3,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,3'-[ 1,4-phenylenebis(methylene)]diphenylamine, 3,3'-[1,3-phenylenebis(methylene)]diphenylamine, 1,4-phenylene bis[( 4-aminophenyl)methanone], 1,4-phenylenebis[(3-aminophenyl)methanone], 1,3-phenylene bis[(4-aminophenyl)-methyl Ketone], 1,3-phenylene bis[(3-aminophenyl)methanone] 1,4-phenylene bis(4-aminobenzoate), 1,4-phenylene bis(3-aminobenzoate), 1,3-phenylene bis(4-amine Benzoate), 1,3-phenylene bis(3-aminobenzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl) Terephthalate, bis(4-aminophenyl)isophthalate, bis(3-aminophenyl)isophthalate, anthracene, Ν'-(1,4- Phenylene) bis(4-aminobenzoguanamine), hydrazine, Ν'-(1,3-phenylene) bis(4-aminobenzophthalamide), hydrazine, Ν'-(1, 4-phenylene) bis(3-aminobenzophthalamide), hydrazine, Ν'-(1,3-phenylene) bis(3-aminobenzophthalamide), hydrazine, Ν'-double (4-Aminophenyl) p-decylamine, hydrazine, Ν'-bis(3-aminophenyl)-p-guanamine, hydrazine, Ν'-bis(4-aminophenyl)isodecylamine ,Ν,Ν'-bis(3-aminophenyl)isodecylamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy) Diphenylanthracene, 2,2'-bis[4-(4-aminophenoxy)phenyl] -18 - 201137037 Propane, 2,2'-bis[4-(4-aminophenoxy) Phenyl]hexafluoro Propane, 2,2'-bis(4-aminophenyl)hexafluoropropane 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4) _Methylphenyl)hexafluoropropane, 2,2'-bis(4-aminophenyl)propane, 2,2,-bis(3-aminophenyl)propane, 2,2,_bis (3 _Amino 4-methylphenyl) propane, 3,5-diaminobenzoic acid, 2,5-diaminobenzoic acid, 1,3-bis(4-aminophenoxy)propyl, l,3-bis(3-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, 1,4-bis(3-aminophenoxy)butane 1,5-bis(4-aminophenoxy)pentane, i,5-bis(3-aminophenoxy)pentane, 16-bis(4-aminophenoxy)hexane, i,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)gum, 1,7-(3-aminophenoxy)glyoxime, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane , i,9-bis(3·aminophenoxy)decane, M〇-(4-aminophenoxy)decane, 1,10-(3-aminophenoxy)decane, 111 -(1 aminobenzene Oxy) undecane, 1,11-(3-aminophenoxy) eleventh, 1,12-(4-aminophenoxy)dodecane, 1;12-(3-amino group An alicyclic diamine such as an aromatic diamine such as phenoxy)dodecane, bis(4-aminocyclohexyl)methane or bis(4-amino-3-methylcyclohexyl)methane; 3-diaminopropyl propyl 1,4-diaminobutane, i,5-diaminopentane, 1,6-diaminohexyl, 1,7-diaminoheptane, 1, 8-Diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 1,11-diaminoundecane, 1,12-diaminododecane, etc. Aliphatic diamine. Further, for example, a diamine having an alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring, a heterocyclic ring or a macrocyclic substituent formed thereon in a side chain of a diamine is specifically, for example, the following The amine of the formula [DA1]~[DA32] is the -19-201137037 amine. [Chemistry 7]

[DA1] CDA2][DA1] CDA2]

[DA5] (式[DA1]〜式[DA5]中,R,爲碳數1以上、22以下之烷基 或含氟之烷基) [化8][DA5] (In the formula [DA1] to the formula [DA5], R is an alkyl group having a carbon number of 1 or more and 22 or less or a fluorine-containing alkyl group] [Chemical Formula 8]

(式[DA6]〜式[DA11]中,R2 爲-COO-'-OCO-'-CONH-、-NHCO-、-CH2-、-Ο-、-CO-或-NH-,R3 爲碳數 1 以 上、22以下之烷基或含氟之烷基) [化9](In the formula [DA6]~form [DA11], R2 is -COO-'-OCO-'-CONH-, -NHCO-, -CH2-, -Ο-, -CO- or -NH-, and R3 is a carbon number 1 or more, 22 or less alkyl or fluorine-containing alkyl groups) [Chemical 9]

(式[DA12]及式[DA13]中,R4 爲-0·、-OCH2-、-CH20-、 -COOCH2或-CH2OCO-,R5爲碳數1以上、22以下之烷 基、烷氧基或含氟之烷基或含氟之烷氧基) -20- 201137037 [化 10](In the formula [DA12] and the formula [DA13], R4 is -0., -OCH2-, -CH20-, -COOCH2 or -CH2OCO-, and R5 is an alkyl group having 1 or more and 22 or less, an alkoxy group or Fluorinated alkyl or fluorine-containing alkoxy) -20- 201137037 [10]

[DAI 4] [DA 15] [DA16] (式[DA14]〜式[DA16]中,R6 爲-COO-'-OCO-'-CONH-、-NHCO-、-COOCH2-、-CH2OCO- ' -CH20-、-OCH” 或 -CH2-,R7爲碳數1以上、22以下之烷基、烷氧基、含氟 之烷基或含氟之烷氧基) [化11][DAI 4] [DA 15] [DA16] (In the formula [DA14]~[DA16], R6 is -COO-'-OCO-'-CONH-, -NHCO-, -COOCH2-, -CH2OCO- ' - CH20-, -OCH" or -CH2-, R7 is an alkyl group having 1 or more and 22 or less carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group)

H2N nh2 [DA1 8]H2N nh2 [DA1 8]

RgRg

(式[DAI 7]及式[DAI 8]中,R 8 爲-C Ο Ο -、- O C Ο -、- C Ο N Η-' -NHCO- > -COOCH2- ' -CH2OCO- > -CH2O- ' -OCH2- ' -CH2-、-O-或-NH-,R9爲氟基、氰基、三氟甲院基、硝 基、偶氮基、甲醯基、乙醯基、乙醯氧基或羥基) [化 12](In the formula [DAI 7] and the formula [DAI 8], R 8 is -C Ο Ο -, - OC Ο -, - C Ο N Η-' -NHCO- > -COOCH2- ' -CH2OCO- > - CH2O- ' -OCH2- ' -CH2-, -O- or -NH-, R9 is a fluorine group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a methyl group, an ethyl group, an ethyl group Oxy or hydroxy) [Chemical 12]

(式[DA19]及式[DA20]中,R10爲碳數3以上、12以下之 -21 - 201137037 烷基,1,4-環己烯之順式-反式向異性各爲反式異構物) [化 13](In the formula [DA19] and the formula [DA20], R10 is a carbon number of 3 or more and 12 or less - 21 - 201137037 alkyl group, and the cis-trans isotropic of 1,4-cyclohexene is trans isomerism. () 13]

HzNHzN

[DA21] [DA22] (式[DA21]及式[DA22]中’ Rii爲碳數3以上、12以下之 烷基,1,4-環己烯之順式-反式向異性各爲反式異構物) [化 14][DA21] [DA22] (In the formula [DA21] and the formula [DA22], ' Rii is an alkyl group having a carbon number of 3 or more and 12 or less, and the cis-trans isotropic of 1,4-cyclohexene is each a trans Isomer) [Chem. 14]

-22- 201137037 [化 15]-22- 201137037 [Chem. 15]

[化 16] / CH3\ ch3 H2N—丨一{CH2h_NH2 [DA33] \ CH3/PCH3 (式[DA33]中,p爲i〜10之整數) 此外’例如下述式[DA34]之二胺。 [化Π] nh2H2N~ci^ .{C H2)ai—Ai—(C H2)巧-A〗-A3.HCHN/CH3\CH3 H2N-丨_{CH2h_NH2 [DA33] \ CH3/PCH3 (p is an integer of i to 10 in the formula [DA33]) Further, for example, a diamine of the following formula [DA34]. [ΠΠ] nh2H2N~ci^ .{C H2)ai—Ai—(C H2) Qiao-A〗-A3.

PA34| (式[DA34]中,A4爲可被氟原子取代之碳數3〜20之烷 基’ A3爲I,4 -環己烯基或1,4 -亞苯基,A2爲氧原子或 -23- 201137037 -COO-*(其中’附有「*」之鍵與A3鍵結),A,爲氧原子 或-COO-*(其中’附有「*」之鍵與(CH2)a2鍵結)。而且, al爲0或1之整數,32爲2〜10之整數,a3爲0或1之 整數) ±述其他的二胺化合物,係視作爲液晶配向膜時之液 晶配向性、電壓保持特性、蓄電荷等之特性而定,可混合 I種或2種以上使用。 <四羧酸二酐> 本發明使用的四羧酸二酐,沒有特別的限制,其具體 例如下述所示。 均苯四甲酸、2,3,6,7-萘四羧酸、1,2,5,6-萘四羧酸、 1,4,5,8-萘四羧酸、2,3,6,7-蒽四羧酸' 1,2,5,6-蒽四羧酸、 3,3’,4,4’-聯苯四羧酸、2,3,3’,4-聯苯四羧酸、雙(3,4-二羧 基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸、雙(3,4-二羧基苯 基)楓、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基) 丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷'雙 (3,4-二羧基苯基)二甲基矽烷、雙(3,4_二羧基苯基)二苯基 矽烷、2,3,4,5-吡啶四羧酸、2,6-雙(3,4-二羧基苯基)口比 啶、3,3,,4,4,-二苯基颯四羧酸、3,4,9,10-茈四羧酸、1,3_ 二苯基-1,2,3,4 -環丁烷四羧酸、氧化二酞基四羧酸、 I,2,3,4-環丁烷四羧酸、1,2,3,4-環戊烷四羧酸、1,2,3,4,5-環己烷四羧酸、1,2,3,4-四甲基-l,2,3,4-環丁烷四羧酸' 1,2-二甲基-i,2,3,4-環丁烷四羧酸、ι,3-二甲基-1,2,3,4-環 -24 - 201137037 丁院四羧酸、〗,2,3,4-環丁烷四羧酸、2,3,4,5-四氫呋喃四 殘酸' 3,4-一殘基環己基琥珀酸、2,3,5_三羧基環戊基 醋酸、3,4-—羧基·^心四氫-丨—萘基琥珀酸〜二環 [3,3,0]辛烷-2,4,6,8-四羧酸、二環[4,3,0]壬烷 _2,4,7,9_ 四 殘酸、二環[4,4,〇卜癸烷-2,4,7,9-四羧酸、二環[4,4,〇]癸 烷-2,4,8,10-四羧酸、三環[6,3,0,0 < 2,6 >]十一烷-3,5,9,11-四钱酸、丁烷四羧酸、4_(2,5-二氧代四 氫呋喃-3-基)-1,2,3,4-四氫萘-1,2-二羧酸、二環[2,2,2]辛- 7-烯-2,3,5,6-四羧酸、5_(2,5_二氧代四氫呋喃基)_3甲基_ 3-環己烷-1,2-二羧酸、四環[^丨,丨,^?]十二烷· 4,5,9,10-四殘酸、3,5,6_三羧基正冰片烷_2:3,5:6二羧酸、 1,2,4,5-環己烷四羧酸等。 四羧酸二酐係視作爲液晶配向膜時之液晶配向性、電 壓保持特性、蓄電荷等之特性而定,可倂用1種或2種以 上。 <聚合物> 本發明之聚合物,係如上所述、以特定的二胺化合物 作爲原料之聚醯胺酸,或使該聚醯胺酸脫水閉環所得的聚 醯亞胺。 由本發明之聚合物所得的液晶配向膜,於上述二胺成 分中特定的二胺化合物的含有比例愈多時,預傾角對熱之 安定性愈爲提高。 爲提高上述特性爲目的時,以二胺成分之1莫耳以上 -25- 201137037 爲特定二胺化合物較佳。另外,以二胺成分之5莫耳%以 上爲特定一胺化合物較佳,以1 〇莫耳%以上更佳。而 且,—胺成分之100莫耳%亦可爲特定的二胺化合物就 塗佈液晶配向處理劑時之均句塗佈性而言’特定二胺化合 物以二胺成分之80莫耳%以下較佳、以4〇莫耳%以下更 佳。 於藉由二胺成分與四羧酸二酐進行反應,製得本發明 之聚醯胺時’可使用習知的合成方法。—般而言,使四羧 酸二酐與二胺在有機溶劑中進行反應的方法。四羧酸二酐 與二胺之反應,在有機溶劑中較爲容易進行,且不會產生 副生成物而言極爲有利》 四羧酸二酐與二胺進行反應時所使用的有機溶劑,只 要是可使生成的聚醯胺酸溶解者即可,沒有特別的限制。 其具體例如下所述。 >1,1<1-二甲基甲醯胺'1^,;^二甲基乙醯胺、:^甲基-2-吡咯烷酮、N -甲基己醯胺、二甲基亞颯、四甲基尿素、口比 啶、二甲基颯、六甲基亞颯、γ-丁內酯、異丙醇、甲氧基 甲基戊醇、二戊烯、乙基戊酮、甲基壬酮、甲基乙酮、甲 基異戊酮、甲基異丙酮、甲基溶纖劑、乙基溶纖劑、甲基 溶纖劑乙酸酯、乙基溶纖劑乙酸酯、丁基卡必醇、乙基卡 必醇、乙二醇、乙二醇單乙酸酯、乙二醇單異丙醚、乙二 醇單丁醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲醚、丙 二醇·第3 -丁醚、二丙二醇單甲醚、二乙二醇、二乙二醇 單乙酸酯、二乙二醇二甲醚、二丙二醇單乙酸酯單甲醚、 •26- 201137037 二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇單乙酸酯單 乙醚、二丙二醇單丙醚、二丙二醇單乙酸酯單丙醚、3-甲 基-3-甲氧基丁基乙酸酯、三丙二醇甲醚、3-甲基-3-甲氧 基丁醇、二異丙醚、乙基異丁醚、二異丁烯、乙酸戊酯、 丁酸丁酯、丁醚、二異丁酮、甲基環己烯、丙醚、二己 醚、二噁烷、正己烷、正戊烷、正辛烷、二乙醚、環己 酮、碳酸乙二酯、碳酸丙二酯、乳酸甲酯、乳酸乙酯、醋 酸甲酯、醋酸乙酯、醋酸正丁酯、醋酸丙二醇單乙醚、三 甲基乙酸甲酯、三甲基乙酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙 酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁 酯、二肟、4-羥基-4-甲基-2-戊酮等。此等可單獨使用, 亦可混合使用。另外、在不會使聚醯胺酸溶解的溶劑、不 會使生成的聚醯胺酸析出的範圍內,亦可混合於上述溶劑 使用。而且,由於有機溶劑中之水分會阻害聚合反應,且 使生成的聚醯胺酸進行水解的原因,以有機溶劑使用經脫 水乾燥者較佳。 使四羧酸二酐與二胺成分在有機溶劑中進行反應時, 例如使在有機溶劑中分散或溶解有二胺之溶液進行攪拌, 直接添加四羧酸二酐、或分散或溶解於有機溶劑中予以添 加的方法,反之,在有機溶劑中分散或溶解有四羧酸二酐 之溶液中添加二胺的方法,相互添加四羧酸二酐與二胺之 方法等’可使用此等之任一方法。此外,爲由複數種四羧 酸二酐或二胺成分之化合物所成時,可以預先混合的狀態 -27- 201137037 進行反應,亦可個別順序進行反應,亦可使個別反應的低 分子量體進丫了混合反應的局分子量體。 使四羧酸二酐與二胺成分進行反應的溫度,可選擇 -2 0°C〜150°C之任意溫度,以- 5°C〜l〇〇°C之範圍較佳。而 且,反應可在任意的濃度下進行,惟,由於濃度過低時, 不易製得高分子量之聚合物,濃度過高時,反應液之黏性 變高,變得不易均勻地進行搅拌,故以1〜50質量%較 佳,以5〜30質量%更佳。反應初期可在高濃度下進行, 再追加有機溶劑。 於聚醯胺酸之聚合物中,四羧酸二酐之合計莫耳數與 二胺成分之合計莫耳數之比例,以0.8〜1 · 2較佳。與一 般的聚縮合反應相同,該莫耳比愈接近1.0時,生成的聚 醯胺酸之分子量變得愈大。 本發明之聚醯亞胺係使上述之聚醯胺酸脫水閉環所得 的聚醯亞胺,爲製得液晶配向膜時作爲聚合物極爲有用。 於本發明之聚醯亞胺中,醯胺酸基之脫水閉環率(醯 亞胺化率),不一定必須爲1 〇〇%,視其用途或目的而定, 例如可調整爲4 5〜8 5 %之範圍等。 使聚醯胺酸予以醯亞胺化的方法,例如使聚醯胺酸之 溶液直接加熱的熱醯亞胺化、在聚醯胺酸之溶液中添加觸 媒之觸媒醯亞胺化。 使聚醯胺酸在溶液中進行熱醯亞胺化時之溫度,爲 100t〜400°C,較佳者爲120T:〜250°C,以使藉由醯亞胺 化反應生成的水除至系外且進行者較佳。 -28- 201137037 聚醯胺酸之觸媒醯亞胺化,可藉由在聚醯胺酸之溶液 中添加鹼性觸媒與酸酐,在-20〜250°C(較佳者爲〇〜 1 8 (TC )下進行攪拌予以進行。鹼性觸媒之量爲醯胺酸基之 0.5〜30莫耳倍、較佳者爲2〜20莫耳倍,酸酐之量爲醯 胺酸基之1〜50莫耳倍、較佳者爲3〜30莫耳倍。鹼性觸 媒例如吡啶、三乙胺、三甲胺、三丁胺、三辛胺等,其 中,吡啶以於進行反應時具有適當鹼性者較佳。酸酐例如 醋酸酐、偏苯三酸酐、均苯四甲酸酐等,其中,使用醋酸 酐時,以反應完成後容易進行精製者較佳。藉由觸媒醯亞 胺化之醯亞胺化率,可藉由調整觸媒量與反應溫度、反應 時間予以控制。 自聚醯胺酸或聚醯亞胺之反應溶液回收生成的聚醯胺 酸或聚醯亞胺時,可將反應溶液投入貧溶劑中,予以沉 澱。沉澱時使用的貧溶劑,例如甲醇、丙酮、己烷、丁基 溶纖劑、庚烷、甲基乙酮、甲基異丁酮、乙醇、甲苯、 苯、水等。投入貧溶劑中予以沉澱的聚合物,可於過濾回 收後,在常壓或減壓下、常溫或加熱下進行乾燥。而且, 使經沉澱回收的聚合物再溶解於有機溶劑、再沉澱回收的 操作重複2〜10次時,可減少聚合物中之雜質。此時之貧 溶劑’例如醇類、酮類、烴等,使用選自此等中之3種以 上的貧溶劑時,可更爲提高精製的效率,故較佳。 本發明之液晶配向處理劑所含的聚醯胺酸及聚醯亞胺 之分子量,就考慮有此所得的塗膜之強度及形成塗膜時之 作業性、塗膜之均句性而言,以GPC(Gel Permeation -29- 201137037PA34| (In the formula [DA34], A4 is an alkyl group having 3 to 20 carbon atoms which may be substituted by a fluorine atom] A3 is I,4-cyclohexenyl or 1,4-phenylene, and A2 is an oxygen atom or -23- 201137037 -COO-* (where 'the key with "*" is linked with A3), A, is the oxygen atom or -COO-* (where 'the key with '*' and the key of (CH2)a2) Further, al is an integer of 0 or 1, 32 is an integer of 2 to 10, and a3 is an integer of 0 or 1.) The other diamine compound is regarded as a liquid crystal alignment property and voltage when used as a liquid crystal alignment film. It is possible to mix one type or two or more types depending on the characteristics of the characteristics and the charge storage. <tetracarboxylic dianhydride> The tetracarboxylic dianhydride used in the present invention is not particularly limited, and specific examples thereof are as follows. Pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic acid, 1,2,5,6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalenetetracarboxylic acid, 2,3,6, 7-蒽tetracarboxylic acid ' 1,2,5,6-nonanetetracarboxylic acid, 3,3',4,4'-biphenyltetracarboxylic acid, 2,3,3',4-biphenyltetracarboxylic acid , bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'-benzophenonetetracarboxylic acid, bis(3,4-dicarboxyphenyl) maple, double (3,4 -dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1,1,3,3,3-hexafluoro-2,2-bis(3,4- Dicarboxyphenyl)propane 'bis(3,4-dicarboxyphenyl)dimethyl decane, bis(3,4-dicarboxyphenyl)diphenyl decane, 2,3,4,5-pyridinetetracarboxylic acid Acid, 2,6-bis(3,4-dicarboxyphenyl)pyridinium, 3,3,4,4,-diphenylstilbenetetracarboxylic acid, 3,4,9,10-decanetetracarboxylic acid Acid, 1,3_diphenyl-1,2,3,4-cyclobutanetetracarboxylic acid, dimercaptotetracarboxylic acid, I,2,3,4-cyclobutanetetracarboxylic acid, 1,2 , 3,4-cyclopentane tetracarboxylic acid, 1,2,3,4,5-cyclohexanetetracarboxylic acid, 1,2,3,4-tetramethyl-l,2,3,4-ring Butane tetracarboxylic acid ' 1,2-dimethyl-i,2,3,4-cyclobutane tetracarboxylic acid, iota, 3-dimethyl-1,2,3,4-cyclo-24 - 201137037 Dingyuan tetracarboxylic acid, 〗 〖, 2,3,4-cyclobutane tetracarboxylic acid, 2,3,4,5-tetrahydrofuran tetraresidic acid '3,4-one residue cyclohexyl succinic acid, 2,3, 5-_Tricarboxycyclopentyl acetic acid, 3,4-carboxyl^-tetrahydro-indole-naphthylsuccinic acid~Bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylate Acid, bicyclo[4,3,0]nonane-2,4,7,9_ tetraresidic acid, bicyclo[4,4,pyridin-2,4,7,9-tetracarboxylic acid, two Cyclo [4,4,〇]decane-2,4,8,10-tetracarboxylic acid, tricyclo[6,3,0,0 < 2,6 >]undecane-3,5,9 , 11-tetramic acid, butane tetracarboxylic acid, 4_(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid, two Ring [2,2,2]oct-7-ene-2,3,5,6-tetracarboxylic acid, 5-(2,5-dioxotetrahydrofuranyl)_3 methyl-3-cyclohexane-1, 2-Dicarboxylic acid, tetracyclo[^丨,丨,^?]dodecane·4,5,9,10-tetraresidic acid, 3,5,6-tricarboxy-norbornane_2:3,5 : 6 dicarboxylic acid, 1,2,4,5-cyclohexanetetracarboxylic acid, and the like. The tetracarboxylic dianhydride may be used in the form of a liquid crystal alignment film, a voltage-holding property, and a charge-accumulating property, and may be used alone or in combination of two or more. <Polymer> The polymer of the present invention is a polyamic acid having a specific diamine compound as a raw material as described above, or a polyimine obtained by dehydrating and ring-closing the polyamic acid. In the liquid crystal alignment film obtained from the polymer of the present invention, the more the content ratio of the specific diamine compound in the above diamine component, the higher the stability of the pretilt angle with respect to heat. In order to improve the above characteristics, it is preferred to use a diamine component of 1 mol or more -25 to 201137037 as a specific diamine compound. Further, it is preferable to use a specific amine compound of 5 mol% or more of the diamine component, more preferably 1 mol% or more. Further, 100 mol% of the amine component may be a specific diamine compound in terms of uniform coating properties when the liquid crystal alignment agent is applied. 'The specific diamine compound is 80 mol% or less of the diamine component. It is better to use 4% or less. When the polyamine component of the present invention is obtained by reacting a diamine component with a tetracarboxylic dianhydride, a conventional synthesis method can be used. In general, a method of reacting a tetracarboxylic acid dianhydride with a diamine in an organic solvent. The reaction of the tetracarboxylic dianhydride with the diamine is relatively easy to carry out in an organic solvent, and is extremely advantageous without the occurrence of by-products. The organic solvent used in the reaction of the tetracarboxylic dianhydride with the diamine is as long as It is possible to dissolve the produced polylysine, and there is no particular limitation. This is specifically described below. >1,1<1-dimethylformamide '1^,;^dimethylacetamide, :methyl-2-pyrrolidone, N-methylhexylamine, dimethyl azine, Tetramethyl urea, pyridine, dimethyl hydrazine, hexamethyl hydrazine, γ-butyrolactone, isopropanol, methoxymethylpentanol, dipentene, ethyl pentanone, methyl hydrazine Ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropanone, methyl cellosolve, ethyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl Carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, Propylene glycol·3rd butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, • 26-201137037 Dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetic acid Ester, tripropylene glycol methyl ether, 3-methyl-3-methoxy Butanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, dibutyl ether, diisobutyl ketone, methyl cyclohexene, propyl ether, dihexyl ether, dioxins Alkane, n-hexane, n-pentane, n-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate , propylene glycol monoethyl ether acetate, methyl trimethylacetate, ethyl trimethylacetate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, 3-methoxypropionic acid Ester, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, diterpene, 4-hydroxy-4-methyl- 2-pentanone and the like. These can be used alone or in combination. Further, it may be used in the above solvent in a range in which the polylysine is not dissolved and the produced polyamine is not precipitated. Further, since the water in the organic solvent hinders the polymerization reaction and causes the produced polyamic acid to be hydrolyzed, it is preferred to use an organic solvent to be dehydrated. When the tetracarboxylic dianhydride and the diamine component are reacted in an organic solvent, for example, a solution in which a diamine is dispersed or dissolved in an organic solvent is stirred, and tetracarboxylic dianhydride is directly added or dispersed or dissolved in an organic solvent. A method of adding the mixture, and a method of adding a diamine to a solution in which a tetracarboxylic dianhydride is dispersed or dissolved in an organic solvent, a method of adding a tetracarboxylic dianhydride and a diamine to each other, etc. A method. Further, when it is composed of a plurality of compounds of a tetracarboxylic dianhydride or a diamine component, the reaction may be carried out in a state of -27-201137037 which is previously mixed, or the reaction may be carried out in an individual order, or the low molecular weight body of the individual reaction may be further advanced. The local molecular weight body of the mixed reaction is smashed. The temperature at which the tetracarboxylic dianhydride and the diamine component are allowed to react may be selected from any temperature of -200 ° C to 150 ° C, preferably in the range of - 5 ° C to 10 ° C. Further, the reaction can be carried out at any concentration. However, when the concentration is too low, it is difficult to obtain a polymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction liquid becomes high, and it becomes difficult to uniformly stir. It is preferably 1 to 50% by mass, more preferably 5 to 30% by mass. The initial stage of the reaction can be carried out at a high concentration, and an organic solvent is added. In the polymer of polyamic acid, the ratio of the total number of moles of the tetracarboxylic dianhydride to the total number of moles of the diamine component is preferably 0.8 to 1.2. As with the general polycondensation reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the produced polylysine becomes. The polyimine of the present invention is a polyimine obtained by dehydrating and ring-closing the polyamic acid described above, and is extremely useful as a polymer when a liquid crystal alignment film is obtained. In the polyimine of the present invention, the dehydration ring closure ratio of the proline group (the imidization ratio) does not necessarily have to be 1%, depending on the purpose or purpose, for example, it can be adjusted to 4 5~ 8 5 % range, etc. A method of imidating polylysine with ruthenium is, for example, a hydrazine imidization in which a solution of polylysine is directly heated, and a catalyst which is added to a solution of polyphthalic acid to imidize. The temperature at which the polyaminic acid is thermally imidized in the solution is from 100 t to 400 ° C, preferably from 120 T: to 250 ° C, to remove water formed by the hydrazine imidization reaction. Out of the line and the performer is better. -28- 201137037 The phthalocyanine of poly-proline is imidized by adding a basic catalyst and an acid anhydride to the solution of poly-proline, at -20~250 ° C (preferably 〇~ 1 The stirring is carried out under 8 (TC). The amount of the alkaline catalyst is 0.5 to 30 moles, preferably 2 to 20 moles, of the proline group, and the amount of the anhydride is 1 of the proline group. ~50 moles, preferably 3 to 30 moles. Basic catalysts such as pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine, etc., wherein pyridine is suitable for carrying out the reaction Preferably, the acidity is, for example, acetic anhydride, trimellitic anhydride, pyromellitic anhydride, etc., wherein when acetic anhydride is used, it is preferred to carry out the purification after completion of the reaction. The imine imine is imidized by the catalyst. The rate can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. When recovering the polylysine or polyimine from the reaction solution of poly-proline or polyimine, the reaction solution can be obtained. It is poured into a poor solvent and precipitated. The poor solvent used in the precipitation, such as methanol, acetone, hexane, butyl cellosolve, Alkane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water, etc. The polymer precipitated in a poor solvent can be filtered and recovered, under normal pressure or reduced pressure, at normal temperature or under heating. Drying is also carried out. Further, when the polymer recovered by precipitation is redissolved in an organic solvent and the operation of reprecipitation is repeated 2 to 10 times, impurities in the polymer can be reduced. At this time, the poor solvent such as alcohols and ketones In the case of a hydrocarbon or the like, when three or more kinds of poor solvents selected from the above are used, the efficiency of the purification can be further improved. Therefore, the polyamine and the polyimine contained in the liquid crystal alignment treatment agent of the present invention are preferred. The molecular weight is considered to be the GPC (Gel Permeation -29-201137037) considering the strength of the coating film obtained and the workability at the time of forming the coating film, and the uniformity of the coating film.

Chfomatography)法測定的重量平均分子量,以 5,000〜 1,000,000 較佳,以〗〇,〇〇〇〜15〇,〇〇〇 更佳。 <液晶配向處理劑> 本發明之液晶配向處理劑,爲形成液晶配向膜時之塗 佈'液’爲形成樹脂被膜時之樹脂成分溶解於有機溶劑之溶 液。此處,上述之樹脂成分係含有至少一種選自上述本發 明之聚合物的聚合物之樹脂成分。此時,樹脂成分之含量 以1質量%〜2 0質量%較佳,以3質量%〜1 5質量%更 佳’以3〜10質量%最佳。 於本發明中,前述之樹脂成分可爲全部本發明所使用 的聚合物,亦可在本發明之聚合物中混合有除此以外之其 他的聚合物。此時,樹脂成分中之其他聚合物的含量,爲 0.5質量%〜15質量%,較佳者爲1質量%〜10質量%。 該其他的聚合物,例如使用除特定二胺化合物外之二 胺作爲與四羧酸二酐進行反應的二胺成分所得的聚醯胺酸 或聚醯亞胺等。 本發明之液晶配向處理劑中所使用的有機溶劑,只要 是可溶解上述樹脂成分之有機溶劑即可,沒有特別的限 制。 本發明之液晶配向處理劑,亦可含有上述以外之成 份。其例如提高塗佈液晶配向處理劑時之膜厚均勻性或表 面平滑性的溶劑或化合物、提高液晶配向膜與基板之密接 性的化合物等。 -30- 201137037 提高膜厚均勻性或表面平滑性之溶劑的具體例’如下 述所示者。 例如,異丙醇、甲氧基甲基戊醇、甲基溶纖劑'乙基 溶纖劑、丁基溶纖劑、甲基溶纖劑乙酸酯、乙基溶纖劑乙 酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯、乙 二醇、乙二醇單乙酸酯、乙二醇單異丙醚、乙二醇單丁 醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲醚、丙二醇-第3-丁醚、二丙二醇單甲醚、二乙二醇、二乙二醇單乙 酸酯、二乙二醇二甲醚、二丙二醇單乙酸酯單甲醚、二丙 二醇單甲醚、二丙二醇單乙醚、二丙二醇單乙酸酯單乙 醚、二丙二醇單丙醚、二丙二醇單乙酸酯單丙醚、3 -甲 基-3-甲氧基丁基乙酸酯、三丙二醇甲醚、3-甲基-3-甲氧 基丁醇、二異丙醚、乙基異丁醚、二異丁烯、乙酸戊酯、 丁酸丁酯、丁醚、二異丁酮、甲基環己烯、丙醚、二己 醚、正己烷、正戊烷、正辛烷、二乙醚 '乳酸甲酯、乳酸 乙酯、醋酸甲酯、醋酸乙酯、醋酸正丁酯、醋酸正丁酯、 醋酸丙二醇單乙醚、三甲基乙酸甲酯、三甲基乙酸乙酯、 3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙 酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙 酯、3-甲氧基丙酸丁酯、1-甲氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基-2-丙醇、丙二醇單乙 酸酯、丙二醇單乙酸酯、丙二醇-1-單甲醚-2-乙酸酯、丙 二醇-1-單乙醚-2-乙酸酯、二丙二醇、2-(2-乙氧基丙氧基) 丙醇、乳酸甲酯、乳酸乙酯、乳酸正丙酯、乳酸正丁酯、 -31 - 201137037 乳酸異戊酯等之具有低表面張力之溶劑等。 提高上述膜厚均勻性或表面平滑性之溶劑 種,亦可複數種混合使用。使用如上述溶劑時 使用量以液晶配向處理劑中所含的溶劑全體之 %較佳,更佳者爲20〜60質量%。 提高膜厚均勻性或表面平滑性之化合物, 面活性劑、聚矽氧烷系界面活性劑、非離子系 等。 更具體而言,例如 F-top EF301 EF352(Tokemu Products 公司製)、Megafac FI R-30(大日本油墨公司製)、Flolite FC43 1 (Sumitomo 3 M 公司製)、A s ah i G u ar d 3 82 、 SC 1 01 、 SC 102 、 SC103 、 SC 104 SC106(Asahi Glass公司製)等。此等之界面活 比例,相對於液晶配向處理劑中含有的樹脂成 量份而言,以0.01〜2質量份較佳,以0.01〜 佳。 提高液晶配向膜與基板之密接性的化合物 如下述所示之含官能性矽烷的化合物或含環 物。 例如3-胺基丙基三甲氧基矽烷、3-胺基丙 矽烷、2_胺基丙基三甲氧基矽烷、2-胺基丙基 烷、Ν·(2-胺基乙基)-3-胺基丙基三甲氧基矽夫 基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲 ’可使用1 ’該溶劑之 5〜80質量 例如氟系界 界面活性劑 、EF303 、 71、 F173 、 FC430 、 AG7 1 0、S-、SC105 、 性劑的使用 分之1 00質 1質量份更 之具體例, 氧基的化合 基三乙氧基 三乙氧基矽 完、N-(2-胺 基丙基三甲 -32- 201137037 氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3_ 胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙 氧基矽烷、N -三乙氧基甲矽烷基丙基三乙三胺、N -三甲氧 基甲矽烷基丙基三乙三胺、10-三甲氧基甲矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基甲矽烷基-1,4,7_三氮雜癸烷、 9-三甲氧基甲矽烷基_3,6-二氮雜壬基乙酸酯、9-三乙氧基 甲矽烷基-3,6-二氮雜壬基乙酸酯、N-苯甲基-3-胺基丙基 三甲氧基矽烷、N-苯甲基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙 氧基矽烷、N-雙(氧化乙烯)_3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷、乙二醇二環氧丙 醚、聚乙二醇二環氧丙醚、丙二醇二環氧丙醚、三丙二醇 二環氧丙醚、聚丙二醇二環氧丙醚、新戊醇二環氧丙醚、 1,6-己二醇二環氧丙醚、丙三醇二環氧丙醚、2,2-二溴化 新戊醇二環氧丙醚、1,3,5,6-四環氧丙基-2,4-己二醇、 N,N,N’,N’·四環氧丙基-m-二甲苯二胺、1,3-雙(N,N-二環 氧丙基胺基甲基)環己烷、>^小,1^’,:^’-四環氧丙基-4,4’-二 胺基二苯基甲烷等。 使用與此等基板密接的化合物時,該化合物之使用量 相對於液晶配向處理劑中含有的樹脂成分之1 〇〇質量份而 言,以0.1〜3質量份較佳,更佳者爲1〜20質量份。未 達〇. 1質量份時,無法期待提高密接性之效果’大於30 質量份時,會有液晶之配向性惡化的情形。 於本發明之液晶配向處理劑中,在不會損害本發明效 -33- 201137037 果之範圍內,除上述外亦可添加以變化液晶 率或導電性等之電特性爲目的之介電體或導 <液晶配向膜•液晶顯示元件> 本發明之液晶配向處理劑,可塗佈於基 後,藉由摩擦處理或光照射等進行配向處理 向用途等沒有進行配向處理,使用作爲液 時,使用的基板只要是透明性高的基板即可 限制,可使用玻璃基板、丙烯酸基板或聚碳 塑膠基板等。而且,使用爲進行液晶驅動時 電極等之基板,就製程簡單化而言較佳。而 晶顯示元件僅在一側之基板時,亦可使用矽 明物,此時之電極亦可使用鋁等之使光反射 液晶配向處理劑之塗佈方法,沒有特別 而言,工業上有篩網印刷、平版印刷、可撓 等進行的方法。其他的塗佈方法,有浸漬法 隙縫塗佈器、旋轉器等,視目的而定可使用 在基板上塗佈液晶配向處理劑後之燒成 等之加熱手段、在50〜300 °C (較佳者爲80~ 劑蒸發,形成塗膜。燒成後塗膜之厚度過厚 示元件之消耗電力而言變得不利,過薄時, 之信賴性降低,故較佳者爲5〜3 00nm,J 1 OOnm。使液晶進行水平配向或傾斜配向時 塗膜藉由摩擦或偏光紫外線照射等進行處理 配向膜之介電 電物質。 板上予以燒成 ,或在垂直配 晶配向膜。此 ,沒有特別的 酸酯基板等之 之形成有ITO 且,反射型液 晶圓等之不透 的材料。 的限制,一般 性印刷、噴墨 、輥塗佈器、 此等。 ,可藉由熱板 -250°c)下使溶 時,就液晶顯 液晶顯示元件 E佳者爲1 〇〜 ,使燒成後之 -34- 201137037 本發明之液晶顯示元件, 之液晶配向處理劑製得附有液 的方法製作液晶晶胞,且作爲 液晶晶胞製作例,如使用 板,在一面基板之液晶配向膜 膜面爲內側,貼合另一面之基 的方法,或在散佈有間隔板;: 後,貼合基板予以密封的方法 較佳者爲1〜30μπι,更佳者爲 如上所述,使用本發明之 晶顯示元件,形成信賴性優異 且高精細的液晶電視等。 【實施方式】 於下述中以實施例更爲詳 等所限制。 係藉由上述方法,由本發明 晶配向膜之基板後,以習知 液晶顯不兀件者。 1對形成有液晶配向膜之基 上散佈間隔板,以液晶配向 板,減壓注入液晶予以密封 L液晶配向膜面上滴下液晶 等。此時之間隔板的厚度, 2 〜1 0 μπι。 液晶配向處理劑所製作的液 者’可適合利用作爲大畫面 細地說明本發明,惟不受此 [實施例] 的合成] [本發明之特定二胺化合 <實施例1> 二胺化合物(4)之合成 -35- 201137037 [化 18]The weight average molecular weight determined by the Chfomatography method is preferably 5,000 to 1,000,000, more preferably 〇, 〇〇〇 1515 〇, 〇〇〇. <Liquid Crystal Alignment Treatment Agent> The liquid crystal alignment treatment agent of the present invention is a coating liquid when a liquid crystal alignment film is formed, and a solution in which a resin component is dissolved in an organic solvent when a resin coating film is formed. Here, the above resin component is a resin component containing at least one polymer selected from the above polymers of the present invention. In this case, the content of the resin component is preferably from 1% by mass to 20% by mass, more preferably from 3% by mass to 15% by mass, and most preferably from 3 to 10% by mass. In the present invention, the above-mentioned resin component may be all of the polymers used in the present invention, and other polymers other than the above may be mixed in the polymer of the present invention. In this case, the content of the other polymer in the resin component is from 0.5% by mass to 15% by mass, preferably from 1% by mass to 10% by mass. The other polymer is, for example, a polyamine or a polyimine obtained by using a diamine other than a specific diamine compound as a diamine component which reacts with a tetracarboxylic dianhydride. The organic solvent to be used in the liquid crystal alignment agent of the present invention is not particularly limited as long as it is an organic solvent capable of dissolving the above resin component. The liquid crystal alignment treatment agent of the present invention may contain components other than the above. For example, a solvent or a compound which improves film thickness uniformity or surface smoothness when a liquid crystal alignment agent is applied, a compound which improves adhesion between a liquid crystal alignment film and a substrate, and the like can be used. -30- 201137037 A specific example of a solvent for improving film thickness uniformity or surface smoothness is as follows. For example, isopropanol, methoxymethylpentanol, methyl cellosolve 'ethyl cellosolve, butyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl Carbitol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol Acetate, propylene glycol monomethyl ether, propylene glycol - 3-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetic acid Ester monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxy Butyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, dibutyl ether , diisobutyl ketone, methyl cyclohexene, propyl ether, dihexyl ether, n-hexane, n-pentane, n-octane, diethyl ether 'methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, vinegar N-butyl ester, n-butyl acetate, propylene glycol monoethyl ether, methyl trimethylacetate, ethyl trimethylacetate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, Ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, 1-methoxy 2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, propylene glycol monoacetate, propylene glycol monoacetic acid Ester, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, 2-(2-ethoxypropoxy)propanol, methyl lactate Ethyl lactate, n-propyl lactate, n-butyl lactate, a solvent having a low surface tension such as -31 - 201137037 isoamyl lactate. The solvent species for improving the uniformity of the film thickness or the surface smoothness may be used in combination of plural kinds. When the solvent is used, the amount of the solvent contained in the liquid crystal alignment agent is preferably from 5% to 60% by mass. A compound which improves film thickness uniformity or surface smoothness, a surfactant, a polyoxyalkylene surfactant, a nonionic system, and the like. More specifically, for example, F-top EF301 EF352 (manufactured by Tokemu Products Co., Ltd.), Megafac FI R-30 (manufactured by Dainippon Ink Co., Ltd.), Flolite FC43 1 (manufactured by Sumitomo 3 M Co., Ltd.), A s ah i G u ar d 3 82 , SC 1 01 , SC 102 , SC103 , SC 104 SC106 (manufactured by Asahi Glass Co., Ltd.). The ratio of the interface activity is preferably 0.01 to 2 parts by mass, more preferably 0.01%, based on the amount of the resin contained in the liquid crystal alignment agent. A compound which improves the adhesion between the liquid crystal alignment film and the substrate is a functional decane-containing compound or a ring-containing material shown below. For example, 3-aminopropyltrimethoxydecane, 3-aminopropane, 2-aminopropyltrimethoxydecane, 2-aminopropylalkane, Ν(2-aminoethyl)-3 -Aminopropyltrimethoxysulfonylethyl)-3-aminopropylmethyldimethoxydecane, 3-urea' can be used as a solvent of 5 to 80 masses such as fluorine-based interfacial activity Agent, EF303, 71, F173, FC430, AG7 1 0, S-, SC105, the use of the agent is divided into 100 parts, 1 part by mass, more specific examples, the compound of the oxy group, triethoxytriethoxy ruthenium N-(2-Aminopropyltrimethyl-32-201137037 oxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N -ethoxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxymethylidenepropyltriethyltriamine, N-trimethoxycarbamidopropyltriethylenetriamine, 10 -trimethoxycarbamido-1,4,7-triazadecane, 10-triethoxycarbamimidyl-1,4,7-triazadecane, 9-trimethoxyformamidinyl _3,6-diazepine acetate, 9-triethoxycarbamido-3,6-diazepine acetic acid , N-Benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxy Decane, N-phenyl-3-aminopropyltriethoxydecane, N-bis(ethylene oxide)-3-aminopropyltrimethoxydecane, N-bis(ethylene oxide)-3-aminopropyl Triethoxy decane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, new Pentanol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibrominated neopentyl diglycidyl ether, 1,3, 5,6-tetraepoxypropyl-2,4-hexanediol, N,N,N',N'·tetraepoxypropyl-m-xylenediamine, 1,3-double (N,N -diglycidylaminomethyl)cyclohexane, >^ small, 1^', :^'-tetraepoxypropyl-4,4'-diaminodiphenylmethane, etc. When the compound is in contact with the substrate, the amount of the compound used is 0.1 to 3 parts by mass based on 1 part by mass of the resin component contained in the liquid crystal alignment agent. Preferably, it is 1 to 20 parts by mass. When it is less than 1 part by mass, the effect of improving the adhesion cannot be expected. When the amount is more than 30 parts by mass, the alignment of the liquid crystal may be deteriorated. In the alignment treatment agent, a dielectric or a conductive liquid for the purpose of changing electrical properties such as liquid crystal ratio or conductivity may be added in addition to the above, in addition to the above-mentioned effects. Membrane/Liquid Crystal Display Device The liquid crystal alignment treatment agent of the present invention can be applied to the substrate by rubbing treatment or light irradiation, and the alignment treatment is not applied to the use or the like. The substrate having high transparency can be limited, and a glass substrate, an acrylic substrate, a polycarbon plastic substrate, or the like can be used. Further, it is preferable to use a substrate for performing liquid crystal driving electrodes or the like in terms of simplification of the process. When the crystal display element is only on one side of the substrate, the sputum may be used. In this case, the electrode may be coated with a light-reflecting liquid crystal alignment treatment agent such as aluminum, and in particular, there is a sieve in the industry. A method of web printing, lithography, and flexibility. Other coating methods include an immersion slit coater, a rotator, etc., depending on the purpose, a heating means such as baking after applying a liquid crystal alignment agent on a substrate, at 50 to 300 ° C (more) The film is evaporated to form a coating film. The thickness of the coating film after baking is too thick to indicate that the power consumption of the device is unfavorable, and when it is too thin, the reliability is lowered, so that it is preferably 5 to 300 nm. J 1 OOnm. When the liquid crystal is horizontally aligned or tilted, the coating film is treated with a dielectric material of the alignment film by rubbing or polarized ultraviolet irradiation, etc. The board is fired or vertically aligned with the alignment film. A special acid ester substrate or the like is formed of ITO, a material that is impermeable to a reflective liquid crystal, or the like, and is generally limited to a general printing, an inkjet, a roll coater, or the like. When the solution is dissolved under °c), the liquid crystal display element E is preferably 1 〇~, and after the firing, the liquid crystal display element of the present invention, the liquid crystal alignment treatment agent is prepared to have a liquid attached thereto. Making a liquid crystal cell and making it as a liquid crystal cell For example, if a plate is used, the liquid crystal alignment film surface of one substrate is inside, the method of bonding the other surface, or the spacer is dispersed; and the method of sealing the bonded substrate is preferably 1~ 30 μm, more preferably, as described above, the crystal display element of the present invention is used to form a liquid crystal television having excellent reliability and high definition. [Embodiment] The following examples are more limited by the examples. According to the above method, after the crystal of the present invention is aligned to the substrate of the film, the liquid crystal is not known. 1 A pair of spacers are formed on the substrate on which the liquid crystal alignment film is formed, and a liquid crystal alignment plate is used, and liquid crystal is injected under reduced pressure to seal the liquid crystal on the L liquid crystal alignment film surface. At this time, the thickness of the separator is 2 to 10 μm. The liquid crystal prepared by the liquid crystal alignment agent can be suitably used as a large screen to explain the present invention in detail, but is not subject to the synthesis of the [Examples] [Specific diamine compound of the present invention <Example 1> Diamine compound (4) Synthesis -35- 201137037 [Chem. 18]

在室溫下、於經氮氣取代的4 口燒瓶中加入3 -甲基-3-氧雜環丁院乙醇(2)(l4.95g、146.4mmol)、三乙胺 (16.29g、I60.1mmol)與四氫呋喃(150nll)後,保持於 15°C 以下,且滴入3,5 -二硝基氯化苯甲醯基 [l](33.70g、 146.2mmol)之四氫呋喃(40ml)溶液。於反應完成後,將反 應液注入1 L之純水中,過濾所得的結晶,以純水洗淨。 使結晶在乙醇(200ml)中進行攪拌後,進行過濾及乙醇洗 淨後,製得化合物(3 )(白色結晶、3 6.3 3 g、得率8 4 %)。 'H-NMR (400MHz,CDCl3,5ppm): 9.2 6 (1 Η, t, J = 2.0 Η z) 、9.16(lH,dd,J=1.2Hz)、4.63 -4.50(4H,m)、4.59(2H,s)、 1 .47(3H,s) 使化合物(3)(30.00g、lOlmmol)與 5% Pd-C(3g)之四 氫呋喃(300ml)的混合物,在氫氣存在、室溫下進行攪 拌。於反應完成後,進行過濾,使氯液在減壓下予以濃 縮。在所得的粗生成物中加入己烷(2 00ml)進行攪拌。於 攪拌後,使結晶過濾、以己烷洗淨。然後,將所得的結晶 加入乙醇(1 00ml)中,進行攪拌後,使結晶過濾,以乙醇 洗淨時,製得二胺化合物(4)(白色結晶、21.45g、得率 9 0%)= -36- 201137037 • 4Hz) 'H-NMR (400MHz,CDCl3,6ppm)·. 6.7 8 (2 H, d , J = 2 ' 6.18(lH,t,J = 2.4Hz)、4.63(2H,d,J = 6.0Hz)、 4.44(2H,d,J = 6.0Hz)、4.32(2H,s) ' 3 · 745 (4H,brord) 1.40(3H,s) [聚醯胺酸及聚醯亞胺之合成] 醯胺酸 聚醯胺 如下所 胺酸及 下述之實施例2〜9及比較例1〜4,係記載聚 或聚醯亞胺之合成例,各記載所使用的簡稱之意、 酸及聚醯亞胺之分子量的測定及醯亞胺化率之測定 述。而且實施例2〜9及比較例1〜4所合成的聚醯 聚醯亞胺之內容,各如表2及表3所示。 (四羧酸二酐) CBDA: 1,2,3,4-環丁烷四羧酸二酐 BODA:二環[3, 3,0]辛烷-2,4,6,8-四羧酸二酐 [化 19]3-methyl-3-oxetanine ethanol (2) (14.95 g, 146.4 mmol) and triethylamine (16.29 g, I60.1 mmol) were added to a nitrogen-substituted 4-neck flask at room temperature. After the reaction with tetrahydrofuran (150 nll), it was kept below 15 ° C, and a solution of 3,5-dinitrobenzyl benzhydryl [l] (33.70 g, 146.2 mmol) in tetrahydrofuran (40 ml) was added dropwise. After completion of the reaction, the reaction solution was poured into 1 L of pure water, and the resulting crystals were filtered and washed with pure water. The crystals were stirred in ethanol (200 ml), filtered, and washed with ethanol to give compound (3) (white crystals, 36.3 g, yield: 84%). 'H-NMR (400MHz, CDCl3, 5ppm): 9.2 6 (1 Η, t, J = 2.0 Η z) , 9.16 (lH, dd, J = 1.2 Hz), 4.63 - 4.50 (4H, m), 4.59 ( 2H, s), 1.47 (3H, s) A mixture of compound (3) (30.00 g, 10 mmol) and 5% Pd-C (3 g) in tetrahydrofuran (300 ml) was stirred in the presence of hydrogen at room temperature. . After completion of the reaction, filtration was carried out to concentrate the chlorine solution under reduced pressure. To the obtained crude product, hexane (200 ml) was added and stirred. After stirring, the crystals were filtered and washed with hexane. Then, the obtained crystals were added to ethanol (100 ml), stirred, and the crystals were filtered, and washed with ethanol to obtain a diamine compound (4) (white crystal, 21.45 g, yield 90%) = -36- 201137037 • 4Hz) 'H-NMR (400MHz, CDCl3, 6ppm)·. 6.7 8 (2 H, d , J = 2 ' 6.18(lH,t,J = 2.4Hz), 4.63(2H,d, J = 6.0 Hz), 4.44 (2H, d, J = 6.0 Hz), 4.32 (2H, s) ' 3 · 745 (4H, brord) 1.40 (3H, s) [Polyuric acid and polyimine Synthesis] Amidin polyamine The following amines and the following Examples 2 to 9 and Comparative Examples 1 to 4 are examples of synthesis of poly or polyimine, and the meanings of the abbreviations and acids used in the respective descriptions. And the measurement of the molecular weight of the polyimine and the measurement of the imidization ratio, and the contents of the polyfluorene polyimides synthesized in Examples 2 to 9 and Comparative Examples 1 to 4 are shown in Table 2 and Table 3, respectively. (tetracarboxylic dianhydride) CBDA: 1,2,3,4-cyclobutane tetracarboxylic dianhydride BODA: bicyclo[3,3,0]octane-2,4,6,8- Tetracarboxylic dianhydride [Chemical 19]

(特定二胺化合物) 二胺(4 ):以實施例1所合成的二胺化合物 -37- 201137037(specific diamine compound) diamine (4): diamine compound synthesized as in Example 1 -37-201137037

(其他的二胺化合物) p-PDA: p-苯二胺 PCH7DAB: 1,3-二胺基-4-[4-(反式-4-正庚基環己基) 苯氧基]苯 PBCH5DAB : 1,3-二胺基-4-{4-(反式- 4-(反式- 4-n-戊基 環己基)環己基)苯氧基}苯 m-PBCH5DAB: 3 ,5-二胺基- {4-[反式-4-(反式- 4- n-戊 基環己基)環己基]苯基}苯甲酸酯 [化 21](Other diamine compounds) p-PDA: p-phenylenediamine PCH7DAB: 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxy]benzene PBCH5DAB: 1,3-Diamino-4-{4-(trans-4-(trans-4-n-pentylcyclohexyl)cyclohexyl)phenoxy}benzene m-PBCH5DAB: 3,5-diamine Base - {4-[trans-4-(trans- 4-n-pentylcyclohexyl)cyclohexyl]phenyl}benzoate [Chem. 21]

(交聯性化合物) KK 1 : [化 22](Crosslinking compound) KK 1 : [Chem. 22]

KK2: -38- 201137037 [化 23] h3cKK2: -38- 201137037 [化23] h3c

KK2 (有機溶劑) Ν Μ P : N _甲基-2 -吡咯烷酮 BCS: 丁基溶纖劑 (聚醯胺酸、聚醯亞胺之分子量的測定) 聚醯胺酸及聚醯亞胺之分子量,係使用昭和電工公司 製常溫凝膠浸透色層分析(GPC)裝置(GPC-101)、Shodex 公司製柱(KD- 8 03、KD-8 05),如下述進行測定。KK2 (organic solvent) Ν Μ P : N _methyl-2-pyrrolidone BCS: butyl cellosolve (measurement of molecular weight of poly phthalic acid, polyimine) molecular weight of poly phthalic acid and polyimine A room temperature gel permeation chromatography (GPC) apparatus (GPC-101) manufactured by Showa Denko Co., Ltd., and a column (KD-803, KD-8 05) manufactured by Shodex Co., Ltd. were used, and the measurement was carried out as follows.

柱溫度:5 0 °C 溶離液:N,N’-二甲基甲醯胺(添加劑爲溴化鋰一水合 物(LiBr . H2O)30mmol/L、磷酸.無水結晶(〇-磷 酸)30mmol/L、四氫呋喃(THF)10ml/L) 流速:1.0ml/分鐘 檢測線作成用標準試樣:Torsol公司製 TSK標準聚 氧化乙烯(分子量 約 900,000、150,000、100, 〇〇〇、 3〇,〇〇〇),及Polymer Laboratory公司製聚乙二醇(分子 量約 12,000、 4,000、 1,000) (醯亞胺化率之測定) 將聚醯亞胺粉末 2〇mg加入NMR試樣管(草野科 學公司製 NMR Sampling Tube Standard Φ 5)中,添加重 -39- 201137037 氫化二甲基亞颯(DMSO-d6、0.05%TMS(四甲基矽烷)混合 品)0.5 3 ml,施加超音波至完全被溶解。使該溶液以】E〇L Datum公司製NMR測定器(JWN-ECA500)測定500MHz之 質子NMR。醯亞胺化率係以來自醯亞胺化前後沒有變化 的構造之質子作爲基準質子決定,使用該質子之波峰累計 値與在9.5至10. Oppm附近所呈現的來自醯胺酸的NH基 之質子波峰累計値,藉由下述式求取。 醯亞胺化率(%) = (1 -a . x/y)x 1 00 於上述式中,x係來自醯胺酸之NH基的質子波峰累 計値,y係基準質子之波峰累積値,α係相對於1個聚醯 胺酸(醯亞胺化率爲0%)時之醯胺酸的ΝΗ基質子爲基準質 子之個數比例。 &lt;實施例2 &gt; 使 BODA(3.51g, 1 4.0mmol) 、 P C Η 7 D A B (0.8 9 g, 2.34mmol)、p-PDA(1.77g、16.4mmol)、二胺(4)(1.10g,、 4.66mmol)在NMP(14.4g)中混合,在80°C下進行反應5小 時後,力D 入 CBDA(1.84g ' 9.38mmol)與 NMP(12.3g),在 40°C下進行反應6小時,製得聚醯胺酸(A)之溶液(濃度 25.4質量%)。該聚醯胺酸之數平均分子量爲23,900、重 量平均分子量爲59,500。 &lt;實施例3 &gt; 與實施例2相同地,在所得的聚醯胺酸(A)之溶液 -40- 201137037 (20.0g)中加入NMP,稀釋成濃度6質量%後,加入作爲醯 亞胺化觸媒之醋酸酐(2.48g)、吡啶(1.90g),在80°C下進 行反應4小時。將該反應溶液注入甲醇(3 00ml)中,過濾 分別生成的沉澱物。使該沉澱物以甲醇洗淨,在1 〇〇°C下 進行減壓乾燥,製得聚醯亞胺(B)之粉末。該聚醯亞胺之 醯亞胺化率爲53%,數平均分子量爲21,300,重量平均分 子量爲51,200。 &lt;實施例4&gt; 於 NMP( 1 4.6g)中混合 BODA(3.48g, 13.9mmol)、 PCH7DAB(0.44g, 1.16mmol)、p-PDA(1.63g、15.1mmol)、 二胺(4)(1 _64g,、6.94mmol),在 8 0 °C下進行反應5小時 後,加入 CBDA(1 .82g、9.27mmol)與 NMP(12.7g),在 4〇°C下進行反應6小時,製得聚醯胺酸(C)之溶液(濃度 24.8質量%)。該聚醯胺酸之數平均分子量爲24,100、重 量平均分子量爲5 9,200。 &lt;實施例5&gt; 與實施例4相同地,在所得的聚醯胺酸(C)之溶液 (20.2g)中加入NMP,稀釋成濃度6質量%後,加入作爲醯 亞胺化觸媒之醋酸酐(2.50g)、毗啶(1.95g),在80°C下進 行反應4小時。將該反應溶液注入甲醇(300ml)中,過濾 分別生成的沉澱物。使該沉澱物以甲醇洗淨,在1 00°C下 進行減壓乾燥’製得聚醯亞胺(D)之粉末。該聚醯亞胺之 -41 - 201137037 醯亞胺化率爲55%’數平均分子量爲22,4〇〇,重量平均分 子量爲52,500 β &lt;實施例6&gt; 在 NMP(17.5g)中混合 B〇DA(3.50g,14.0mm〇l)、 PCH7D AB(4.44g, 1 1 · 7 m mo 1)、p _ p d A (1 . 0 1 g、9 · 3 4 m m 〇1) ' 二胺(4)(0.55g,、2.33mmol),在80°C下進行反應5小時 後,加入 CBDA(1.83g、9.33mmol)與 NMP(15.9g),在 40°C下進行反應6小時’製得聚醯胺酸溶液(濃度25.3質 量%)。 在所得的聚醯胺酸溶液(20.0g)中加入NMP,稀釋成 濃度6質量%後,加入作爲醯亞胺化觸媒之醋酸酐 (4.5 3g)、吡啶(3.3 1g),在90°C下進行反應3小時。將該 反應溶液注入甲醇(3 10ml)中,過濾分別生成的沉澱物。 使該沉澱物以甲醇洗淨,在1 〇〇t下進行減壓乾燥,製得 聚醯亞胺(E)之粉末。該聚醯亞胺之醯亞胺化率爲80%, 數平均分子量爲16,300,重量平均分子量爲45,400。 &lt;實施例7&gt; 在 NMP(14.9g)中混合 BODA(3.50g, 14.0mmol)、 PCH5D AB(0.50g, 1 .1 6 mm ο 1)、p - P D A (1 . 8 9 g、1 7 · 5 mm ο 1)、 二胺(4)(1.10g,、4.66mmol)’在80°C下進行反應5小時 後,加入 CBDA(1.83g、9.33mmol)與 NMP(12.3g)’ 在 4 0 °C下進行反應6小時,製得聚醯胺酸溶液(濃度2 4.5質 -42- 201137037 量%)。 在所得的聚醯胺酸溶液(20.〇g)中加入NMP,稀釋成 濃度6質量%後,加入作爲醯亞胺化觸媒之醋酸酐 (2.45g)、吡啶(1 .93g),在8〇t下進行反應4小時。將該 反應溶液注入甲醇(2 8 0ml)中,過濾分別生成的沉澱物。 使該沉澱物以甲醇洗淨,在1〇〇。(:下進行減壓乾燥,製得 聚醯亞胺(F)之粉末。該聚醯亞胺之醯亞胺化率爲55%, 數平均分子量爲22,600,重量平均分子量爲53,100。 &lt;實施例8&gt; 在 NMP(16_5g)中混合 BODA(3.55g, 14.2mmol)、 PCH5DAB(3.07g, 7.10mmol)、p-PDA(1.28g、11.8mmol)、 二胺(4)(1.12g,、4.74mm〇l),在80°C下進行反應5小時 後,加入 CBDA(1 _86g、9.48mmol)與 NMP(15.9g),在 4 〇°C下進行反應6小時,製得聚醯胺酸溶液(濃度25.2質 量 〇/〇)。 在所得的聚醯胺酸溶液(20.5 g)中加入NMP ’稀釋成 濃度 6質量%後’加入作爲醯亞胺化觸媒之醋酸酐 (4.50g)、吡啶(3.30g) ’在90°C下進行反應3小時。將該 反應溶液注入甲醇(330ml)中’過濾分別生成的沉澱物。 使該沉澱物以甲醇洗淨’在.1 0 0 °C下進行減壓乾燥’製得 聚醯亞胺(G)之粉末。該聚醯亞胺之醯亞胺化率爲81 % ’ 數平均分子量爲16,100,重量平均分子量爲44,800。 -43 - 201137037 &lt;實施例9&gt; 在 NMP(16.4g)中混合800八(3.50§,14.〇111111〇1)、111-PCH5DAB(3 . 1 2g, 7 · 0 0 m m ο 1)、p - P D A (1 · 2 6 g、1 1 · 7 m m ο 1)、 二胺(4)(1.10g,、4.66mmol),在 80°C下進行反應 5小時 後,加入 CBDA(1 .83g、9.33mmol)與 NMP(1 5.3g),在 4〇°C下進行反應6小時,製得聚醯胺酸溶液(濃度25.4質 量%)。 在所得的聚醯胺酸溶液(20.0 g)中加入NMP,稀釋成 濃度 6質量%後,加入作爲醯亞胺化觸媒之醋酸酐 (2.4 8g)、吡啶(1.95g),在8 0°C下進行反應4小時。將該 反應溶液注入甲醇(3 00ml)中,過濾分別生成的沉澱物。 使該沉澱物以甲醇洗淨,在l〇〇°C下進行減壓乾燥,製得 聚醯亞胺(H)之粉末。該聚醯亞胺之醯亞胺化率爲55%, 數平均分子量爲1 8,200,重量平均分子量爲48,500。 &lt;比較例1 &gt; 在 NMP(13.1g)中混合 BODA(3.53g, M.lmmol)、 PCH7DAB(0.89g, 2.3 4m m ο 1)、p - P D A (2.2 9 g、2 1 . 2 m m ο 1), 在 80°C下進行反應 5小時後,加入 CBDA(1.85g、 9.43mmol)與NMP(12.4g),在40°C下進行反應6小時,製 得聚醯胺酸(I)之溶液(濃度25.0質量%)。該聚醯亞胺酸之 數平均分子量爲25,400,重僵平均分子量爲63,3 00。 &lt;比較例2 &gt; -44- 201137037 與合成例1相同地,在所得的聚醯胺酸(I)之溶液 (2 0.0g)中加入NMP,稀釋成濃度6質量%後,加入作爲醯 亞胺化觸媒之醋酸酐(2.48g)、吡啶(1.92g),在8(TC下進 行反應4小時。將該反應溶液注入甲醇(2 90ml)中,過濾 分別生成的沉澱物。使該沉澱物以甲醇洗淨,在100°C下 進行減壓乾燥,製得聚醯亞胺(J)之粉末。該聚醯亞胺之 醯亞胺化率爲55%’數平均分子量爲22,300,重量平均分 子量爲56,300。 &lt;比較例3&gt; 在 NMP(1 7.3g)中混合 BODA(3.51g, 14.0mmol)、 PCH7D AB(4.45g, 1 1 _ 7 m m ο 1)、p - P D A (1.2 6 g ' 1 1 . 7 m m ο 1), 在 8 0 °C下進行反應 5小時後,加入 C B D A (1 . 8 3 g、 9.3 3 mmol)與NMP (15.3 g),在4(TC下進行反應6小時,製 得聚醯胺酸溶液(濃度25.3質量%)。 在所得的聚醯胺酸溶液(2 0 . 1 g)中加入Ν Μ P,稀釋成 濃度 6質量%後,加入作爲醯亞胺化觸媒之醋酸酌: (4.5〇g)、吡啶(3.30g)’在90°C下進行反應3小時。將該 反應溶液注入甲醇(3 2〇ml)中,過濾分別生成的沉澱物。 使該沉澱物以甲醇洗淨,在1 〇〇°C下進行減壓乾燥,製得 聚醯亞胺(K)之粉末。該聚醯亞胺之醯亞胺化率爲80%, 數平均分子量爲16,100,重量平均分子量爲44,2〇〇。 &lt;比較例4&gt; -45- 201137037 在 NMP(16.2g)中混合 BODA(3.50g,14.0mmol)、 PCH5DAB(3.03g, 7.00mmol)、p-PDA(1.77g、16.4mmol), 在 80°C下進行反應 5小時後,加入 CBDA(1.83g、 9.33mmol)與NMP(15.0g),在40°C下進行反應6小時,製 得聚醯胺酸溶液(濃度24.5質量%)。 在所得的聚醯胺酸溶液(20.0g)中加入NMP,稀釋成 濃度 6質量%後,加入作爲醯亞胺化觸媒之醋酸酐 (4.4 8 g)、吡啶(3.2 8 g),在9 0 °C下進行反應3小時。將該 反應溶液注入甲醇(320ml)中’過濾分別生成的沉澱物。 使該沉澱物以甲醇洗淨’在l〇〇°C下進行減壓乾燥’製得 聚醯亞胺(L)之粉末。該聚醯亞胺之醯亞胺化率爲81%’ 數平均分子量爲19,500,重量平均分子量爲49,400。 -46 - 201137037 [表2] 聚合物 四羧酸二酐 [g/rnnol] 二胺成分 [g/mmol] 醯亞胺化率 (%) 實施例2 聚醯胺酸(A) C6DA [1.84/9. 38] B0DA[3. 51/14.0] 二胺(4) D. 10/4. 66] PCH7DAB[0. 89/2. 34] p-PDA[l. 77/16. 4] 實施例3 聚醯亞胺(B) CBDA [1.84/9. 38] B0DA[3. 51/14.0] 二胺(4) [1. 10/4. 66] PCH7DAB [0. 89/2. 34] p-PDA[l. 77/16. 4] 5 3 實施例4 聚酿胺酸(C) CBDA [1. 82/9.27] B0DA[3.48/13.9] 二胺(4) [1.64/6. 94] PCH7DAB[0. 44/1.16] p-PDA[l. 63/15.1] 實施例5 聚醯亞胺(D) CBDA [1.82/9. 27] B0DA[3. 48/13.9] 二胺(4) [1· 64/6. 96] PCH7DAB[0. 44/1. 16] p-PDA[l. 63/15.1] 5 5 實施例6 聚醯亞胺(E) CBDAtl.83/9. 33] B0DA[3. 50/14. 0] 二胺(4) [0. 55/2. 33] PCH7DAB[4.44/11. 7] p-PDA[l.01/9.34] 8 0 實施例7 聚醯亞胺(F) CBDA [1. 83 /9.33] BODA [3. 50/14.0] 二胺(4) [1. 10/4. 66] PBCH5DAB[0. 50/1. 16] p-PDA [1.89/17. 5] 5 5 實施例8 聚醯亞胺(G) CBDA [1. 86/9.48] B0DA[3. 55/14. 2] 二胺(4) [1. 12/4. 74] PBCH5DAB[3. 07/7. 10] p-PDA[1.28/11.8] 8 1 實施例9 聚醢亞胺(H) CBDA [1.83/9. 33] BODA[3. 50/14.0] 二胺(4) [1. 10/4. 66] m-PBCH5DAB[3.12/7.00] p-PDA[1.26/ll. 7] 5 5 [表3] 聚合物 四羧酸二酐 [g/mmol] 二胺成分 [g/mmol] 酿亞胺化率 (%) 比較例1 聚醯胺酸α) CBDA [1. 85/9.43] B0DA[3. 53/14. l] PCH7DAB[0. 89/2. 34] p-PDA[2. 29/21. 2] 比較例2 聚醯亞胺⑺ CBDA[1.85/9. 43] B0DA[3. 53/14.1] PCH7DAB[0. 89/2. 34] p-PDA [2. 29/21. 2] 5 5 比較例3 聚醯亞胺(Κ) CBDA [1. 83/9. 33] B0DA[3. 51/14.0] PCH7DAB[4 45/11.7] p-PDA [1. 26/11. 7] 8 0 比較例4 聚醯亞胺(L) CBDA [1. 83/9. 33] B0DA[3_ 50/14.0] PBCH5DAB[3. 03/7. 00] p-PDA[l. 77/16. 4] 8 1 [液晶配向處理劑之製造] 下述之實施例1 〇〜1 7及比較例5〜1 1中,記載液晶 配向處理劑之製造例,爲評估各液晶配向處理劑時使用的 [液晶晶胞之製作]、[液晶配向性及預傾角之評估]及[電特 -47- 201137037 性之評估],如下所述。而且,實施例1 〇〜1 7及比較例5 〜1 1所得的各液晶配向處理劑之內容及特性,各如表4 及表5所示。 [液晶晶胞之製作] 在3x4cm附有ΙΤΟ電極之ΙΤΟ面上旋轉塗覆液晶配 向處理劑’在熱板上、80°C下進行加熱處理5分鐘,在熱 循環型乾淨烤箱中、210 °C下進行加熱處理30分鐘,製得 膜厚lOOnm之聚醯亞胺塗膜。使塗膜面以輥徑120mm、 雷縈布之摩擦裝置、回轉數 7〇〇rpm、移動速度 40mm/sec、押入量0 · 3 m m之條件進行摩擦處理,製得附 有液晶配向膜之基板。使用2枚附有該液晶配向膜之基 板,以液晶配向膜面爲內側,以6μιη之間隔夾住,以與 摩擦方向相反的方向組合,以密封劑黏合周圍,製作空晶 胞。在該空晶胞中以減壓注入法注入液晶(Merck . Japan 公司製、ZLI-2293)、封住注入口,製得反向平行配向的 向列型液晶晶胞(以下亦稱爲液晶晶胞)。惟於實施例1 4、 實施例1 6、實施例1 7、比較例3〜比較例7中,使用 MLC-6608 (Merck . Japan 公司製)作爲液晶。 [液晶配向性及預傾角之評估]Column temperature: 50 °C Dissolution: N, N'-dimethylformamide (additive is lithium bromide monohydrate (LiBr. H2O) 30 mmol / L, phosphoric acid. Anhydrous crystal (〇-phosphoric acid) 30 mmol / L, Tetrahydrofuran (THF) 10 ml/L) Flow rate: 1.0 ml/min Test line for standard preparation: TSK standard polyethylene oxide manufactured by Torsol Co., Ltd. (molecular weight: about 900,000, 150,000, 100, 〇〇〇, 3 〇, 〇〇〇) Polyethylene glycol (molecular weight: about 12,000, 4,000, 1,000) manufactured by Polymer Laboratory Co., Ltd. (measurement of ruthenium imidation rate) 2 〇mg of polyimine powder was added to NMR sample tube (NMR produced by Kusano Scientific Co., Ltd.) In Sampling Tube Standard Φ 5), add 0.5-201137037 hydrogenated dimethyl hydrazine (DMSO-d6, 0.05% TMS (tetramethyl decane) mixture) 0.5 3 ml, apply ultrasonic waves to completely dissolve. This solution was measured for proton NMR at 500 MHz by an NMR measuring instrument (JWN-ECA500) manufactured by E.L. Datum. The ruthenium imidization ratio is determined by using a proton having a structure which has not changed before and after the imidization as a reference proton, and the peak of the proton is used to form an average of 値 and the NH group derived from lysine which is present in the vicinity of 9.5 to 10. Oppm. The proton peaks are cumulatively obtained by the following formula. Ruthenium amination rate (%) = (1 - a . x / y) x 1 00 In the above formula, x is the proton peak accumulation 醯 from the NH group of proline, and the peak accumulation of the y-based reference proton, The ratio of the alpha matrix to the ruthenium matrix of lysine relative to one polylysine (the oxime iodization rate is 0%) is the ratio of the number of reference protons. &lt;Example 2 &gt; BODA (3.51 g, 1 4.0 mmol), PC Η 7 DAB (0.8 9 g, 2.34 mmol), p-PDA (1.77 g, 16.4 mmol), diamine (4) (1.10 g) , 4.66 mmol), mixed in NMP (14.4 g), and reacted at 80 ° C for 5 hours, then force D into CBDA (1.84 g ' 9.38 mmol) and NMP (12.3 g), and react at 40 ° C A solution of polyamic acid (A) (concentration: 25.4% by mass) was obtained for 6 hours. The polyamic acid had a number average molecular weight of 23,900 and a weight average molecular weight of 59,500. &lt;Example 3 &gt; In the same manner as in Example 2, NMP was added to the obtained solution of polyamic acid (A)-40-201137037 (20.0 g), diluted to a concentration of 6 mass%, and then added as a yam. Acetylation catalyst acetic anhydride (2.48 g) and pyridine (1.90 g) were reacted at 80 ° C for 4 hours. The reaction solution was poured into methanol (300 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a powder of polyimine (B). The polyimine had a ruthenium iodide ratio of 53%, a number average molecular weight of 21,300, and a weight average molecular weight of 51,200. &lt;Example 4&gt; BODA (3.48 g, 13.9 mmol), PCH7DAB (0.44 g, 1.16 mmol), p-PDA (1.63 g, 15.1 mmol), and diamine (4) were mixed in NMP (14.6 g). 1 _64 g, 6.94 mmol), after reacting at 80 ° C for 5 hours, CBDA (1.82 g, 9.27 mmol) and NMP (12.7 g) were added, and the reaction was carried out at 4 ° C for 6 hours. A solution of polylysine (C) (concentration 24.8% by mass). The polyamic acid had a number average molecular weight of 24,100 and a weight average molecular weight of 594,200. &lt;Example 5&gt; In the same manner as in Example 4, NMP was added to the obtained solution of polylysine (C) (20.2 g), diluted to a concentration of 6 mass%, and then added as a ruthenium-based catalyst. Acetic anhydride (2.50 g) and pyridine (1.95 g) were reacted at 80 ° C for 4 hours. The reaction solution was poured into methanol (300 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a powder of polyimine (D). The polyimine of -41 - 201137037 has a ruthenium amination rate of 55% 'the number average molecular weight is 22,4 〇〇, and the weight average molecular weight is 52,500 β &lt;Example 6&gt; Mixing B in NMP (17.5 g) 〇DA (3.50g, 14.0mm〇l), PCH7D AB (4.44g, 1 1 · 7 m mo 1), p _ pd A (1.01 g, 9 · 3 4 mm 〇1) 'diamine ( 4) (0.55 g, 2.33 mmol), after reacting at 80 ° C for 5 hours, CBDA (1.83 g, 9.33 mmol) and NMP (15.9 g) were added, and the reaction was carried out at 40 ° C for 6 hours. Polylysine solution (concentration 25.3% by mass). NMP was added to the obtained polyaminic acid solution (20.0 g), and diluted to a concentration of 6 mass%, and acetic anhydride (4.53 g) and pyridine (3.31 g) as a ruthenium amide catalyst were added at 90 ° C. The reaction was carried out for 3 hours. The reaction solution was poured into methanol (3 10 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 Torr to obtain a powder of polyimine (E). The polyimine had an oxime imidization ratio of 80%, a number average molecular weight of 16,300, and a weight average molecular weight of 45,400. &lt;Example 7&gt; BODA (3.50 g, 14.0 mmol), PCH5D AB (0.50 g, 1.16 mm ο 1), p-PDA (1.89 g, 1 7) were mixed in NMP (14.9 g). · 5 mm ο 1), diamine (4) (1.10 g, 4.66 mmol) ' After reacting at 80 ° C for 5 hours, CBDA (1.83 g, 9.33 mmol) and NMP (12.3 g) were added at 4 The reaction was carried out at 0 ° C for 6 hours to obtain a polyaminic acid solution (concentration 2 4.5 mass - 42 - 201137037 %). NMP was added to the obtained polyamic acid solution (20. g), diluted to a concentration of 6 mass%, and then acetic anhydride (2.45 g) and pyridine (1.93 g) as a ruthenium catalyst were added. The reaction was carried out for 4 hours at 8 Torr. The reaction solution was poured into methanol (280 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol at 1 Torr. (: The powder of polyimine (F) was obtained by drying under reduced pressure. The polyamidimide had a ruthenium imidation ratio of 55%, a number average molecular weight of 22,600, and a weight average molecular weight of 53,100. Example 8&gt; BODA (3.55 g, 14.2 mmol), PCH5DAB (3.07 g, 7.10 mmol), p-PDA (1.28 g, 11.8 mmol), diamine (4) (1.12 g, 4.74) were mixed in NMP (16_5g). Mm〇l), after reacting at 80 ° C for 5 hours, CBDA (1 - 86 g, 9.48 mmol) and NMP (15.9 g) were added, and the reaction was carried out at 4 ° C for 6 hours to obtain a polyamidonic acid solution. (concentration: 25.2 mass 〇 / 〇). After adding NMP 'diluted to a concentration of 6 mass% in the obtained polyamidic acid solution (20.5 g), 'added acetic anhydride (4.50 g) as a ruthenium amide catalyst, pyridine (3.30 g) 'The reaction was carried out at 90 ° C for 3 hours. The reaction solution was poured into methanol (330 ml) to 'filter the separately formed precipitate. The precipitate was washed with methanol' at .10 ° C The powder of the polyimine (G) was obtained by drying under reduced pressure. The polyamidimide had a ruthenium iodide ratio of 81% and a number average molecular weight of 16,100 and a weight average molecular weight of 44,800. 43 - 201137037 &lt;Example 9&gt; 8008 (3.50 §, 14.〇111111〇1), 111-PCH5DAB (3.12 g, 7 · 0 0 mm ο 1), p was mixed in NMP (16.4 g) - PDA (1 · 2 6 g, 1 1 · 7 mm ο 1), diamine (4) (1.10 g, 4.66 mmol), and reacted at 80 ° C for 5 hours, then added CBDA (1.83 g, 9.33 mmol) and NMP (1 5.3 g) were reacted at 4 ° C for 6 hours to obtain a polyaminic acid solution (concentration: 25.4% by mass). The obtained polyglycine solution (20.0 g) was added. NMP was diluted to a concentration of 6 mass%, and acetic anhydride (2.48 g) and pyridine (1.95 g) as a ruthenium-imiding catalyst were added, and the reaction was carried out for 4 hours at 80 ° C. The reaction solution was poured into methanol ( The precipitate formed separately was filtered in 300 ml. The precipitate was washed with methanol, and dried under reduced pressure at 10 ° C to obtain a powder of polyimine (H). The imidization ratio was 55%, the number average molecular weight was 1,800, and the weight average molecular weight was 48,500. <Comparative Example 1 &gt; BODA (3.53 g, M.lmmol) and PCH7DAB were mixed in NMP (13.1 g) ( 0.89g, 2.3 4m m ο 1), p - PDA (2.2 9 g, 2 1 . 2 mm ο 1), after reacting at 80 ° C for 5 hours, CBDA (1.85 g, 9.43 mmol) and NMP (12.4 g) were added, and the reaction was carried out at 40 ° C for 6 hours. A solution of polyamine (I) (concentration: 25.0% by mass) was obtained. The polyimine has a number average molecular weight of 25,400 and an average dead weight of 63,300. &lt;Comparative Example 2 &gt; -44-201137037 In the same manner as in Synthesis Example 1, NMP was added to a solution (20.0 g) of the obtained polyaminic acid (I), and the mixture was diluted to a concentration of 6 mass%, and then added as a hydrazine. The imidization catalyst acetic anhydride (2.48 g) and pyridine (1.92 g) were reacted at 8 (TC for 4 hours). The reaction solution was poured into methanol (2 90 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a powder of polyimine (J). The polyamidimide had a hydrazine imidization ratio of 55% and a number average molecular weight of 22,300. The weight average molecular weight was 56,300. &lt;Comparative Example 3&gt; BODA (3.51 g, 14.0 mmol), PCH7D AB (4.45 g, 1 1 _ 7 mm ο 1), p-PDA (1.2) were mixed in NMP (1 7.3 g). 6 g '1 1 . 7 mm ο 1), after reacting at 80 ° C for 5 hours, adding CBDA (1.83 g, 9.3 3 mmol) and NMP (15.3 g), at 4 (TC) The reaction was carried out for 6 hours to obtain a polyaminic acid solution (concentration: 25.3% by mass). Ν Μ P was added to the obtained polyaminic acid solution (200 g), diluted to a concentration of 6 mass%, and then added as a hydrazine. Imine exposure The acetic acid of the medium: (4.5 〇g), pyridine (3.30 g)' was reacted at 90 ° C for 3 hours. The reaction solution was poured into methanol (32 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 1 ° C to obtain a powder of polyimine (K). The polyamidimide had an oxime imidization ratio of 80% and a number average molecular weight of 16,100, weight average molecular weight was 44,2 〇〇. &lt;Comparative Example 4&gt; -45- 201137037 BODA (3.50 g, 14.0 mmol), PCH5DAB (3.03 g, 7.00 mmol), p- were mixed in NMP (16.2 g). PDA (1.77 g, 16.4 mmol) was reacted at 80 ° C for 5 hours, and then CBDA (1.83 g, 9.33 mmol) and NMP (15.0 g) were added, and the reaction was carried out at 40 ° C for 6 hours to obtain a polyfluorene. Amino acid solution (concentration: 24.5% by mass). NMP was added to the obtained polyaminic acid solution (20.0 g), diluted to a concentration of 6 mass%, and acetic anhydride (4.4 8 g) as a ruthenium catalyst was added. Pyridine (3.2 8 g) was reacted for 3 hours at 90 ° C. The reaction solution was poured into methanol (320 ml) to filter the precipitates formed separately. The precipitate was washed with methanol to dry under reduced pressure at 10 ° C to obtain a powder of polyimine (L). The polyamidimide had a ruthenium iodide ratio of 81%', a number average molecular weight of 19,500, and a weight average molecular weight of 49,400. -46 - 201137037 [Table 2] Polymer tetracarboxylic dianhydride [g/rnnol] Diamine component [g/mmol] oxime imidization ratio (%) Example 2 Polyglycine (A) C6DA [1.84/ 9. 38] B0DA [3. 51/14.0] Diamine (4) D. 10/4. 66] PCH7DAB [0. 89/2. 34] p-PDA [l. 77/16. 4] Example 3 Polyimine (B) CBDA [1.84/9. 38] B0DA [3. 51/14.0] Diamine (4) [1. 10/4. 66] PCH7DAB [0. 89/2. 34] p-PDA [l. 77/16. 4] 5 3 Example 4 Polylactoic acid (C) CBDA [1. 82/9.27] B0DA [3.48/13.9] Diamine (4) [1.64/6. 94] PCH7DAB[0 44/1.16] p-PDA [l. 63/15.1] Example 5 Polyimine (D) CBDA [1.82/9. 27] B0DA [3. 48/13.9] Diamine (4) [1· 64 /6. 96] PCH7DAB [0. 44/1. 16] p-PDA [l. 63/15.1] 5 5 Example 6 Polyimine (E) CBDAtl.83/9. 33] B0DA [3. 50 /14. 0] Diamine (4) [0. 55/2. 33] PCH7DAB [4.44/11. 7] p-PDA [l.01/9.34] 8 0 Example 7 Polyimine (F) CBDA [1. 83 /9.33] BODA [3. 50/14.0] Diamine (4) [1. 10/4. 66] PBCH5DAB [0. 50/1. 16] p-PDA [1.89/17. 5] 5 5 Example 8 Polyimine (G) CBDA [1. 86/9.48] B0DA [3. 55/14. 2] Diamine (4) [1. 12/4. 74] PBCH5DAB [3. 07/7 . 10] p-PDA[1.28/11 .8] 8 1 Example 9 Polyimine (H) CBDA [1.83/9. 33] BODA [3. 50/14.0] Diamine (4) [1. 10/4. 66] m-PBCH5DAB [3.12 /7.00] p-PDA [1.26/ll. 7] 5 5 [Table 3] Polymer tetracarboxylic dianhydride [g/mmol] Diamine component [g/mmol] Brewing imidization ratio (%) Comparative Example 1 Poly (proline) α) CBDA [1. 85/9.43] B0DA [3. 53/14. l] PCH7DAB [0. 89/2. 34] p-PDA [2. 29/21. 2] Comparative Example 2醯imine (7) CBDA [1.85/9. 43] B0DA [3. 53/14.1] PCH7DAB [0. 89/2. 34] p-PDA [2. 29/21. 2] 5 5 Comparative Example 3 Polysaccharide Amine (Κ) CBDA [1. 83/9. 33] B0DA [3. 51/14.0] PCH7DAB [4 45/11.7] p-PDA [1. 26/11. 7] 8 0 Comparative Example 4 Polyimine (L) CBDA [1. 83/9. 33] B0DA[3_ 50/14.0] PBCH5DAB[3. 03/7. 00] p-PDA[l. 77/16. 4] 8 1 [Liquid alignment treatment agent [Production] In the following Examples 1 to 7 and Comparative Examples 5 to 1 1, a production example of a liquid crystal alignment treatment agent was used, and [liquid crystal cell production] and [liquid crystal] used for evaluation of each liquid crystal alignment treatment agent were used. Evaluation of Orientation and Pretilt Angle] and [Evaluation of Sex-47-201137037], as described below. Further, the contents and characteristics of each of the liquid crystal alignment treatment agents obtained in Examples 1 to 17 and Comparative Examples 5 to 1 are shown in Tables 4 and 5. [Production of liquid crystal cell] Rotating and coating a liquid crystal alignment agent on a 3x4 cm surface with a ruthenium electrode 'heat treatment on a hot plate at 80 ° C for 5 minutes, in a heat cycle type clean oven, 210 ° Heat treatment was carried out for 30 minutes at C to obtain a polyimide film having a film thickness of 100 nm. The coating film surface was rubbed with a roll diameter of 120 mm, a friction device of a Thunder cloth, a number of revolutions of 7 rpm, a moving speed of 40 mm/sec, and a pushing amount of 0 · 3 mm to obtain a substrate with a liquid crystal alignment film. . Two substrates with the liquid crystal alignment film were used, and the liquid crystal alignment film surface was placed inside, sandwiched at intervals of 6 μm, and combined in a direction opposite to the rubbing direction, and the periphery was adhered with a sealant to prepare an empty cell. Liquid crystal (manufactured by Merck. Japan, ZLI-2293) was injected into the empty cell by a vacuum injection method, and the injection port was sealed to obtain an antiparallel alignment nematic liquid crystal cell (hereinafter also referred to as liquid crystal crystal). Cell). In the case of Example 14 4, Example 16 and Example 17, and Comparative Example 3 to Comparative Example 7, MLC-6608 (manufactured by Merck. Japan Co., Ltd.) was used as the liquid crystal. [Evaluation of liquid crystal alignment and pretilt angle]

有關上述之[液晶晶胞之製作]所得的液晶晶胞,於液 晶注入後(初期)、在95°C下進行加熱處理5分鐘後(表4 中之處理1)及在120°C下進行加熱處理5小時後、於95°C -48- 201137037 下進行加熱處理5分鐘後(表4中之處理2),各進行測定 預傾角。預傾角係測定液晶晶胞之中心及自中心至上下 1 cm之處等3處’以此等之平均値作爲預傾角之値。此 時,測定係在室溫下使用預傾角測定裝置(E L S IC Ο N公司 製 Model PAS-301) ° 而且’有關初期及各加熱處理後之液晶晶胞,藉由偏 光顯微鏡觀察’確認液晶之配向均勻性。液晶爲均勻的配 向狀態者評估爲〇,有液晶之配向混亂情形者評估爲X。 [電特性之評估] 對以上述之[液晶晶胞之製作]所得的液晶晶胞,在 80 °C之溫度下施加4V之電壓60ps,測定16.67ms後及 1 6 67ms後之電壓,求得電壓可保持的程度作爲電壓保持 率(表5中之初期電壓保持率)。 另外,將電壓保持率測定後之液晶晶胞放置於設定於 l〇(TC之恆溫槽中21日,與上述相同地進行電壓保持率 (表5中之高溫放置後之電壓保持率)。 [摩擦耐性之評估] 以共焦點雷射顯微鏡觀察上述之[液晶晶胞之製作]所 得的摩擦處理後之附有液晶配向膜的基板表面,確認有無 摩擦傷痕。 沒有摩擦傷痕者爲〇,有摩擦傷痕者爲 -49- 201137037 &lt;實施例〗〇&gt; 與實施例2相同地,使所得的聚醯胺酸(A)之溶液 (10.2g)、NMP(9.71g)及 BCS(20.0g)在 25°C 下混合 12 小 時,製得液晶配向處理劑[1 ]»該液晶配向處理劑沒有混 濁或析出等之異常情形,可確認爲均勻的溶液。 &lt;實施例11&gt; 與贲施例3相同地,使所得的聚醯亞胺(B )之粉末 (2.51g)、NMP(24·5g)及BCS(ll·6g)在50°C下混合15小 時,製得液晶配向處理劑(2)。該液晶配向處理劑沒有混 濁或析出等之異常情形,可確認爲均勻的溶液。 &lt;實施例12&gt; 與a施例4相同地,使所得的聚醯胺酸(c)之溶液 (1 0.5g)、NMP(1 1.6g)及 BCS(1 8.0g)在 25°C 下混合 12 小 時,製得液晶配向處理劑(3) »該液晶配向處理劑沒有混 濁或析出等之異常情形,可確認爲均勻的溶液。 &lt;實施例1 3&gt; 與實施例5相同地,使所得的聚醯亞胺(D)之粉末 (2.50g)、NMP(18.7g)及 BCS(17.3g)在 5〇°C下混合 15 小 時,製得液晶配向處理劑(4)。該液晶配向處理劑沒有混 濁或析出等之異常情形,可確認爲均勻的溶液。 -50- 201137037 &lt;實施例1 4 &gt; 與實施例6相同地’使所得的聚醯亞胺(£)之粉末 (2.55g)、NMP(26.9g)及 BCS(9.8lg)在 50。。下混合 15 小 時,製得液晶配向處理劑(5)。該液晶配向處理劑沒有混 濁或析出等之異常情形,可確認爲均勻的溶液。 &lt;實施例15&gt; 與實施例7相同地’使所得的聚醯亞胺(F)之粉末 (2.48g)、NMP(16.6g)及 BCS(19.2g)在 50°C 下混合 15 小 時’製得液晶配向處理劑(6)。該液晶配向處理劑沒有混 濁或析出等之異常情形,可確認爲均勻的溶液。 &lt;實施例1 6 &gt; 與實施例8相同地,使所得的聚醯亞胺(G)之粉末 (2.5〇g)、NMP(28.3g)及 BCS(7.69g)在 50°C 下混合 15 小 時’製得液晶配向處理劑(7)。該液晶配向處理劑沒有混 淘或析出等之異常情形,可確認爲均勻的溶液。 &lt;實施例17&gt; 與實施例9相同地,使所得的聚醯亞胺(H)之粉末 (2,5〇g)、NMP(22.6g)及 BCS(13.40g)在 50°C 下混合 15 小 時’製得液晶配向處理劑(8)。該液晶配向處理劑沒有混 淘或析出等之異常情形,可確認爲均勻的溶液。 -51 - 201137037 &lt;比較例5&gt; 與比較例1相同地’使所得的聚醯胺酸(I)之溶液 (l〇.5g)、NMP(9.71g)及 BCS(20.2g)在 2 5。(:下混合 1 2 小 時,製得液晶配向處理劑(9)。 &lt;比較例6 &gt; 與比較例2相同地’使所得的聚醯亞胺之粉末 (2.45g)、NMP(24.0g)及 B C S (1 1 . 3 g)在 5 〇 °C 下混合 1 5 小 時,製得液晶配向處理劑(1 0)。 &lt;比較例7 &gt; 與比較例3相同地,使所得的聚醯亞胺(K)之粉末 (2.50g)、NMP(26.4g)及BCS(9·62g)在50°C下混合15小 時,製得液晶配向處理劑(Π )。 &lt;比較例8 &gt; 與比較例3相同地,使所得的聚醯亞胺(K)之粉末 (2.45g)、NMP(31.1g)、BCS(11.3g)及交聯性化合物 KK 1(0.4 9g)在50 °C下混合15小時,製得液晶配向處理劑 (12)。 &lt;比較例9&gt; 使比較例4所得的聚醯亞胺(L)之粉末(2.50g) ' NMPinJg^BCSdl.Sg)及交聯性化合物 KKl(0.50g)在 -52- 201137037 5 〇 °C下混合15小時,製得液晶配向處理劑(13)。 &lt;比較例1 0 &gt; 與比較例3相同地,使所得的聚醯亞胺(K)之粉末 (2.48g)、NMP(32.0g)、BCS(ll.lg)及交聯性化合物 KK2(0.50g)在50°C下混合15小時,製得液晶配向處理劑 (14)。 &lt;比較例1 1 &gt; 與比較例4相同地,使所得的聚醯亞胺(L)之粉末 (2.52g)、NMP(31.8g)、BCS(11.4g)及交聯性化合物 KK2(0.51g)在50°C下混合15小時,製得液晶配向處理劑 (15) ° [表4] 液晶配向處 〖理劑 預作 mo 配向性 摩擦耐性 聚合物 交聯性 聚合物 初期 處理1 處理2 實施例10 聚醯胺酸(A) 7.8 7.8 7.7 〇 〇 實施例11 聚醢亞胺(B) 6.8 6.7 6.6 〇 6 實施例12 聚醯胺酸(Q 4. 1 4.1 4.0 〇 6 實施例13 聚醯亞胺(D) 3. 5 3.5 3.4 〇 δ 實施例14 聚醯亞胺(E) 88.2 88.3 88. 3 〇 6 實施例15 聚醯亞胺(F) 7.5 7.6 7.5 〇 〇 實施例16 聚醢亞胺⑹ 84.3 84.5 84, 5 〇 〇 實施例17 聚醢亞胺(H) 89.2 89.1 89.2 〇 〇 比較例5 聚醯胺酸(I) 7.3 Γ 7.3 6.4 X X 比較例6 聚醢亞胺(J) 6.2 6.1 5.3 X X 比較例7 聚醯亞胺(K) 85.3 85,4 85.5 X X 比較例8 聚醯亞胺ΠΟ KK1 87.6 87.6 87.8 〇 〇 比較例9 聚醯亞胺(L) KK1 84.8 84,8 卜84. 9 〇 〇 比較例10 聚醯亞胺ΠΟ KK2 87.4 87.5 87.6 〇 〇 比較例11 聚醯亞胺(D KK2 84.6 84.7 84.8 〇 〇 -53- 201137037 [表5] 液晶配向處理劑 電壓保持率(%) * 初 期 髙溫放置後 聚合物 交聯性 化合物 16. 67ms 1667ms 16. 67ms 1667ms 實施例10 聚醯胺酸(A) 97.3 65. 1 96. 3 64.2 實施例11 聚醯亞胺(B) 98.2 67.5 97.9 67. 1 實施例12 聚醯胺酸(C) 97.4 65.4 96.7 64.9 實施例13 聚醯亞胺(D) 98.4 67.6 98. 2 67.3 實施例14 聚醯亞胺(E) 98.9 .68.8 98.8 68.8 實施例15 聚醯亞胺(F) 98.3 67,5 97.8 67.0 實施例16 聚醯亞胺(G) 98.8 68,8 98.7 68.6 實施例17 聚醯亞胺(H) 98,5 68.4 98. 2 68.2 比較例5 聚醯胺酸(I) 97. 1 65.0 94. 5 63. 1 比較例6 聚醯亞胺⑴ 98. 1 67.5 96.9 65.8 比較例7 聚醯亞胺(K) 98.4 67.5 97.2 66.6 比較例8 聚醯亞胺(K) KK1 98.4 68.2 97.0 65.2 比較例9 聚醯亞胺(L) KK1 98.3 68.1 96.9 65.0 比較例10 聚醯亞胺(K) KK2 98.5 68.4 97. 1 65. 6 比較例11 聚醯亞胺(K) KK2 98.6 68.5 97.5 66.0 由上述結果可知,由實施例1 〇〜1 7之液晶配向處理 劑所得的液晶配向膜,具有均勻的配向性,且可提高預傾 角對熱之安定性,且即使長時間暴露於高溫下仍可抑制電 壓保持率降低的情形。另外,由比較例5〜7之液晶配向 處理劑所得的液晶配向膜,可觀察到因摩擦所導致之傷痕 的液晶配向混亂情形。另外,在1 2 0 °C下進行加熱處理5 小時後(熱處理2),預傾角大爲降低。此外’由比較例8 〜1 1之液晶配向處理劑所得的液晶配向膜,對初期之電 壓保持率而言,高溫放置後之電壓保持率大爲降低。 而且,實施例1 〇、1 2與比較例5相比時’及實施例 1 1、1 3〜1 7與比較例6、7相比時,實施例之液晶配向處 理劑所得的液晶配向膜,沒有伴隨摩擦處理之擦傷情形’ 且預傾角對熱之安定性大爲提高。藉此,由此等實施例之 液晶配向處理劑所得的液晶配向膜,即使在長時間、高溫 -54- 201137037 環境下使用或放置時之嚴苛條件中,仍可製得不會產生顯 示斑之液晶顯示元件。 此外,實施例1 〇、12與比較例9相比,實施例1 1、 1 3〜1 7與比較例6、7相比時,由實施例之液晶配向處理 劑所得的液晶配向膜,即使長時間暴露於高溫下,仍可抑 制電壓保持率降低的情形。藉此,由此等實施例之液晶配 向處理劑所得的液晶配向膜,即使在過於嚴苛的條件下, 仍可製得不會產生液晶顯示元件之顯示不佳的線燒成情形 之信賴高的液晶顯示元件。 另外,由比較例8〜1 1之液晶配向處理劑所得的液晶 配向膜,對初期之電壓保持率而言,高溫放置後之電壓保 持率大爲降低。 [產業上之利用價値] 本發明之液晶配向處理劑,於TN元件' S TN元件、 TFT液晶元件及垂直配向型液晶顯示元件等有用,特別是 適合利用於大畫面且高精細的液晶電視等。 而且,於2009年12月25日申請的日本專利申請 2009-29 5 1 8 0號之說明書、申請專利範圍及摘要的全部內 容皆引用於本發明,作爲本發明說明書之揭示所採用者。 -55-The liquid crystal cell obtained by the above [manufacture of liquid crystal cell] was subjected to heat treatment at 95 ° C for 5 minutes after the liquid crystal injection (initial) (treatment 1 in Table 4) and at 120 ° C. After heat treatment for 5 hours, heat treatment was performed at 95 ° C -48 - 201137037 for 5 minutes (treatment 2 in Table 4), and the pretilt angle was measured for each. The pretilt angle is measured at the center of the liquid crystal cell and at a distance of 1 cm from the center to the upper and lower sides, and the average enthalpy is used as the pretilt angle. In this case, the measurement was performed at room temperature using a pretilt angle measuring apparatus (Model PAS-301 manufactured by ELS IC Co., Ltd.) ° and 'relevant liquid crystal cell after initial and each heat treatment, and observed by a polarizing microscope' Orientation uniformity. The liquid crystal is evaluated as 〇 for a uniform alignment state, and X is evaluated for a liquid crystal alignment disorder. [Evaluation of Electrical Characteristics] The liquid crystal cell obtained by the above [Production of Liquid Crystal Cell] was applied with a voltage of 4 V at a temperature of 80 ° C for 60 ps, and the voltage after 16.67 ms and after 16 6 ms was measured. The degree to which the voltage can be maintained is taken as the voltage holding ratio (initial voltage holding ratio in Table 5). In addition, the liquid crystal cell after the measurement of the voltage holding ratio was placed in a thermostat bath set at 1 Torr for 21 days, and the voltage holding ratio (the voltage holding ratio after the high temperature standing in Table 5) was performed in the same manner as above. Evaluation of the frictional resistance] The surface of the substrate with the liquid crystal alignment film after the rubbing treatment obtained by the above-mentioned [liquid crystal cell production] was observed by a confocal laser microscope to confirm the presence or absence of frictional scratches. The scar was -49-201137037 <Example> 〇> In the same manner as in Example 2, a solution (10.2 g) of the obtained polyamic acid (A), NMP (9.71 g), and BCS (20.0 g) were obtained. The mixture was mixed at 25 ° C for 12 hours to obtain a liquid crystal alignment treatment agent [1 ]». The liquid crystal alignment treatment agent was found to be a uniform solution without turbidity or precipitation, etc. &lt;Example 11&gt; 3, the obtained polyimine (B) powder (2.51 g), NMP (24. 5 g) and BCS (ll·6 g) were mixed at 50 ° C for 15 hours to obtain a liquid crystal alignment treatment agent ( 2) The liquid crystal alignment agent has no abnormality such as turbidity or precipitation, and can be confirmed to be uniform. Solution. <Example 12> In the same manner as in Example 4, the obtained solution of polylysine (c) (1 0.5 g), NMP (1 1.6 g) and BCS (1 8.0 g) were at 25°. C is mixed for 12 hours to obtain a liquid crystal alignment treatment agent (3). The liquid crystal alignment treatment agent has no abnormality such as turbidity or precipitation, and can be confirmed as a uniform solution. <Example 1 3> The same as Example 5 The obtained polyimine (D) powder (2.50 g), NMP (18.7 g) and BCS (17.3 g) were mixed at 5 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (4). The liquid crystal alignment treatment agent was not found to be a turbid or precipitated abnormality, and was confirmed to be a homogeneous solution. -50-201137037 &lt;Example 1 4 &gt; In the same manner as in Example 6, 'the obtained polyimine (£) The powder (2.55 g), NMP (26.9 g), and BCS (9.8 lg) were mixed at 50° C. for 15 hours to obtain a liquid crystal alignment treatment agent (5). The liquid crystal alignment treatment agent had no abnormality such as turbidity or precipitation. It was confirmed that it was a homogeneous solution. <Example 15> In the same manner as in Example 7, the obtained polyimine (F) powder (2.48 g), NMP (16.6 g), and BCS (19) were obtained. .2g) The liquid crystal alignment treatment agent (6) was prepared by mixing at 50 ° C for 15 hours. The liquid crystal alignment treatment agent was free from abnormalities such as turbidity or precipitation, and was confirmed to be a uniform solution. [Example 1 6 &gt In the same manner as in Example 8, the obtained polyimine (G) powder (2.5 〇g), NMP (28.3 g), and BCS (7.69 g) were mixed at 50 ° C for 15 hours to obtain a liquid crystal alignment. Treatment agent (7). The liquid crystal alignment agent was not abnormally mixed, such as elution or precipitation, and was confirmed to be a uniform solution. &lt;Example 17&gt; The obtained polyimine (H) powder (2,5 〇g), NMP (22.6 g), and BCS (13.40 g) were mixed at 50 ° C in the same manner as in Example 9. The liquid crystal alignment treatment agent (8) was produced in 15 hours. The liquid crystal alignment agent was not abnormally mixed, such as elution or precipitation, and was confirmed to be a uniform solution. -51 - 201137037 &lt;Comparative Example 5&gt; In the same manner as in Comparative Example 1, the obtained solution of polylysine (I) (10 g), NMP (9.71 g), and BCS (20.2 g) were used in 2 5 . (: The mixture was mixed for 12 hours to obtain a liquid crystal alignment treatment agent (9). &lt;Comparative Example 6 &gt; In the same manner as in Comparative Example 2, the obtained polyimine powder (2.45 g) and NMP (24.0 g) were obtained. And BCS (1 1.3 g) were mixed at 5 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (10). &lt;Comparative Example 7 &gt; In the same manner as in Comparative Example 3, the obtained polymerization was carried out. The powder of quinone imine (K) (2.50 g), NMP (26.4 g) and BCS (9·62 g) were mixed at 50 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (Π). &lt;Comparative Example 8 &gt In the same manner as in Comparative Example 3, the obtained polyimine (K) powder (2.45 g), NMP (31.1 g), BCS (11.3 g), and crosslinkable compound KK 1 (0.4 9 g) were at 50 °. The liquid crystal alignment treatment agent (12) was obtained by mixing for 15 hours under C. <Comparative Example 9> The powder of the polyimine (L) obtained in Comparative Example 4 (2.50 g) 'NMPinJg^BCSdl.Sg) and The compound KK1 (0.50 g) was mixed at -52 to 201137037 5 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (13). &lt;Comparative Example 1 0 &gt; In the same manner as in Comparative Example 3, the obtained polyimine (K) powder (2.48 g), NMP (32.0 g), BCS (ll.lg), and crosslinkable compound KK2 were obtained. (0.50 g) was mixed at 50 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (14). &lt;Comparative Example 1 1 &gt; In the same manner as in Comparative Example 4, the obtained polyimine (L) powder (2.52 g), NMP (31.8 g), BCS (11.4 g), and crosslinkable compound KK2 ( 0.51 g) was mixed at 50 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (15) ° [Table 4] Liquid crystal alignment [Protective agent pre-mo-oriented friction-resistant polymer cross-linking polymer initial treatment 1 treatment 2 Example 10 Polyproline (A) 7.8 7.8 7.7 〇〇 Example 11 Polyimine (B) 6.8 6.7 6.6 〇 6 Example 12 Polyamide (Q 4. 1 4.1 4.0 〇 6 Example 13 Polyimine (D) 3. 5 3.5 3.4 〇δ Example 14 Polyimine (E) 88.2 88.3 88. 3 〇 6 Example 15 Polyimine (F) 7.5 7.6 7.5 〇〇 Example 16 Polymerization醢imine (6) 84.3 84.5 84, 5 〇〇 Example 17 Polyimine (H) 89.2 89.1 89.2 〇〇Comparative Example 5 Polyproline (I) 7.3 Γ 7.3 6.4 XX Comparative Example 6 Polyimine (J 6.2 6.1 5.3 XX Comparative Example 7 Polyimine (K) 85.3 85,4 85.5 XX Comparative Example 8 Polyimine ΠΟ KK1 87.6 87.6 87.8 〇〇Comparative Example 9 Polyimine (L) KK1 84.8 84,8卜84. 9 〇〇 Comparative Example 10 Polyimine ΠΟ KK2 87.4 87.5 87.6 〇〇Comparative Example 11 Polyimine (D KK2 84.6 84.7 84.8 〇〇-53- 201137037 [Table 5] Liquid crystal alignment agent voltage retention rate (%) * Initial 髙Polymer-crosslinkable compound after warming 16.67 ms 1667 ms 16. 67 ms 1667 ms Example 10 Polyproline (A) 97.3 65. 1 96. 3 64.2 Example 11 Polyimine (B) 98.2 67.5 97.9 67. 1 Example 12 Polyproline (C) 97.4 65.4 96.7 64.9 Example 13 Polyimine (D) 98.4 67.6 98. 2 67.3 Example 14 Polyimine (E) 98.9 .68.8 98.8 68.8 Example 15醯imine (F) 98.3 67,5 97.8 67.0 Example 16 Polyimine (G) 98.8 68,8 98.7 68.6 Example 17 Polyimine (H) 98,5 68.4 98. 2 68.2 Comparative Example 5 Proline (I) 97. 1 65.0 94. 5 63. 1 Comparative Example 6 Polyimine (1) 98. 1 67.5 96.9 65.8 Comparative Example 7 Polyimine (K) 98.4 67.5 97.2 66.6 Comparative Example 8 Polysaccharide Amine (K) KK1 98.4 68.2 97.0 65.2 Comparative Example 9 Polyimine (L) KK1 98.3 68.1 96.9 65.0 Comparative Example 10 Polyimine (K) KK2 98.5 68.4 97. 1 65. 6 Comparative Example 11 Amine (K) KK2 98.6 68.5 97.5 66.0 From the above results, it is understood that the liquid crystal alignment film obtained from the liquid crystal alignment treatment agent of Example 1 to has a uniform alignment property and can improve the stability of the pretilt angle to heat. Moreover, even if it is exposed to a high temperature for a long period of time, the situation in which the voltage holding ratio is lowered can be suppressed. Further, in the liquid crystal alignment film obtained by the liquid crystal alignment treatment agents of Comparative Examples 5 to 7, the liquid crystal alignment disorder due to the scratch caused by the rubbing was observed. Further, after heat treatment at 1 2 0 ° C for 5 hours (heat treatment 2), the pretilt angle was greatly lowered. Further, the liquid crystal alignment film obtained from the liquid crystal alignment treatment agents of Comparative Examples 8 to 1 had a large voltage holding ratio after high-temperature placement for the initial voltage holding ratio. Further, in the case of the first embodiment, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the example was compared with the case of the comparative example 5, and the examples 1 1 and 13 3 to 17 were compared with the comparative examples 6 and 7. There is no scratching condition accompanying the rubbing treatment' and the pretilt angle greatly improves the heat stability. Thereby, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present embodiment can be produced without occurrence of display spots even under severe conditions during use or placement in a long-term, high-temperature environment of -54-201137037. Liquid crystal display element. Further, in Examples 1 and 12, compared with Comparative Example 9, the liquid crystal alignment film obtained from the liquid crystal alignment treatment agent of the example was obtained even when the examples 1 1 and 1 3 to 17 were compared with the comparative examples 6 and 7. When exposed to high temperatures for a long time, the voltage holding rate can be suppressed from being lowered. Thereby, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present embodiment can be obtained with high reliability even in an extremely severe condition, and can be produced without causing poor display of the liquid crystal display element. Liquid crystal display element. Further, in the liquid crystal alignment film obtained from the liquid crystal alignment treatment agents of Comparative Examples 8 to 11, the initial voltage holding ratio was greatly lowered after the high temperature standing. [Industrial use price 値] The liquid crystal alignment treatment agent of the present invention is useful for TN elements 'S TN elements, TFT liquid crystal elements, and vertical alignment type liquid crystal display elements, and is particularly suitable for use in large-screen and high-definition liquid crystal televisions. . The entire contents of the specification, the scope of the application, and the abstract of the Japanese Patent Application No. 2009-29 5 190, filed on Dec. 25, 2009, are hereby incorporated by reference. -55-

Claims (1)

201137037 七、申請專利範圍 1. 一種液晶配向處理劑,其特徵爲含有選自由使含 以式π]所示之二胺化合物的二胺成分與四羧酸二酐反應 所得的聚醯胺酸,及使該聚醯胺酸進行脫水閉環所得的聚 醯亞胺所成群中至少1種的聚合物,201137037 VII. Patent application scope 1. A liquid crystal alignment treatment agent characterized by containing a polyamic acid selected from the group consisting of a diamine component containing a diamine compound represented by formula π] and a tetracarboxylic dianhydride. And at least one polymer of the group of polyimine obtained by subjecting the polyamic acid to dehydration ring closure, (式[1]中,Χι 爲-Ο-、-NH-、、N(CH3)-、-CONH-、 -NHCO-、-CH20-、-COO-、-OCO-、-CON(CH3)-,或 -N(CH3)CO-,x2爲單鍵、碳數1〜20之脂肪族烴基、非 芳香族環式烴基,或芳香族烴基,X3爲單鍵、-〇-、-:^1·!-、-N(CH3)-、-CONH·、-NHCO-、-COO-、-OCO-、 -CON(CH3)-、-N(CH3)CO-或,-0(CH2)m-(m 爲 1〜5 之整 數),X4係表示碳數1〜20之有機基,η爲1〜4之整 數)。 2. 如申請專利範圍第1項之液晶配向處理劑,其中 式[1]之Χ2爲單鍵或碳數1〜5之伸院基。 3. 如申請專利範圍第1項或第2項之液晶配向處理 劑,其中式[1]之Χ4爲碳數1〜5之烷基。 4_如申請專利範圍第1〜3項中任一項之液晶配向處 理劑,其中式[1]之Χι爲- 0-、-CONH-,或- COO·,Χ3爲 單鍵或- 0-,η爲1。 -56- 201137037 5 ·如申請專利範圍第1〜4項中任一項之液晶配向處 理劑,其中二胺成分中之5〜80莫耳%爲以式[】]所示之二 胺化合物。 6 · —種液晶配向膜,其特徵爲使用如申請專利範圍 第1〜5項中任一項之液晶配向處理劑所得者。 7. —種液晶顯示元件,其特徵爲具有如申請專利範 圍第6項之液晶配向膜。 8. —種二胺化合物’其特徵爲以下述式[1]表示 [化2](In the formula [1], Χι is -Ο-, -NH-, N(CH3)-, -CONH-, -NHCO-, -CH20-, -COO-, -OCO-, -CON(CH3)- , or -N(CH3)CO-, x2 is a single bond, an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group, or an aromatic hydrocarbon group, and X3 is a single bond, -〇-, -:^1 ·!-, -N(CH3)-, -CONH·, -NHCO-, -COO-, -OCO-, -CON(CH3)-, -N(CH3)CO- or,-0(CH2)m- (m is an integer of 1 to 5), X4 represents an organic group having 1 to 20 carbon atoms, and η is an integer of 1 to 4). 2. In the liquid crystal alignment treatment agent of claim 1, wherein Χ2 of the formula [1] is a single bond or a carbon number of 1 to 5. 3. The liquid crystal alignment treatment agent according to Item 1 or 2 of the patent application, wherein Χ4 of the formula [1] is an alkyl group having 1 to 5 carbon atoms. The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein Χι of the formula [1] is -0-, -CONH-, or -COO·, Χ3 is a single bond or -0- , η is 1. The liquid crystal alignment agent according to any one of claims 1 to 4, wherein 5 to 80 mol% of the diamine component is a diamine compound represented by the formula []. A liquid crystal alignment film which is obtained by using the liquid crystal alignment treatment agent according to any one of claims 1 to 5. A liquid crystal display element characterized by having a liquid crystal alignment film according to item 6 of the patent application. 8. A diamine compound' characterized by the following formula [1] [Chemical 2] [1] (式[1]中,又1爲-0-、-NH-、-N(CH3)-、-CONH-、 -NHCO-、-CH20-、-COO-、-OCO-、-CON(CH3)-,或 -N(CH3)CO-,X2爲單鍵、碳數1〜20之脂肪族烴基、非 芳香族環式烴基,或芳香族烴基,X3爲單鍵、-Ο-、-NH_ 、-N(CH3)-、-CONH-…NHCO-、-COO-、-OCO-、 -CON(CH3)-、-N(CH3)CO-,或-CKCHOn^m 爲 1〜5 之整 數),X4係表示碳數1〜20之有機基,η爲1〜4之整 數)° 9.—種聚醯亞胺,其特徵爲使含有如申請專利範圍 第8項之以式[1 ]所示之二胺化合物的二胺成分,與四羧 酸二酐反應所得的聚醯胺酸,或使該聚醯胺酸進行脫水閉 環所得者。 -57- 201137037 四、指定代表圊: (一) 本案指定代表圖為:無 (二) 本代表圖之元件符號簡單說明:無 五、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:式(1) (化1)[1] (In the formula [1], 1 is -0-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH20-, -COO-, -OCO-, -CON (CH3)-, or -N(CH3)CO-, X2 is a single bond, an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group, or an aromatic hydrocarbon group, and X3 is a single bond, -Ο-, -NH_, -N(CH3)-, -CONH-...NHCO-, -COO-, -OCO-, -CON(CH3)-, -N(CH3)CO-, or -CKCHOn^m is 1~5 Integer), X4 represents an organic group having 1 to 20 carbon atoms, and η is an integer of 1 to 4). 9. A polyimine, which is characterized by containing the formula [1] as in the scope of claim 8 The diamine component of the diamine compound shown, the polylysine obtained by reacting with a tetracarboxylic dianhydride, or the polyglycolic acid is subjected to dehydration ring closure. -57- 201137037 IV. Designation of representatives: (1) The representative representative of the case is: No (2) The symbol of the symbol of the representative figure is simple: No. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention. :式(1) (化1) [1][1]
TW099145804A 2009-12-25 2010-12-24 A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same TWI494374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009295180 2009-12-25

Publications (2)

Publication Number Publication Date
TW201137037A true TW201137037A (en) 2011-11-01
TWI494374B TWI494374B (en) 2015-08-01

Family

ID=44195659

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099145804A TWI494374B (en) 2009-12-25 2010-12-24 A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same

Country Status (5)

Country Link
JP (1) JP5614412B2 (en)
KR (1) KR101759753B1 (en)
CN (1) CN102667594B (en)
TW (1) TWI494374B (en)
WO (1) WO2011078132A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102135493B1 (en) * 2013-05-01 2020-08-26 닛산 가가쿠 가부시키가이샤 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR102275484B1 (en) * 2013-10-23 2021-07-08 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP7067472B2 (en) * 2016-06-14 2022-05-16 日産化学株式会社 Liquid crystal alignment agent and liquid crystal display element for coating BOA substrate or substrate with BCS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100427529C (en) * 2003-11-26 2008-10-22 日产化学工业株式会社 Liquid crystal alignment treating agent for vertical alignment and liquid crystal display
JP4779974B2 (en) * 2004-12-22 2011-09-28 日産化学工業株式会社 Liquid crystal aligning agent and liquid crystal display element using the same
CN101600989B (en) * 2006-11-01 2012-01-25 日产化学工业株式会社 Agent for alignment treatment of liquid crystal and liquid crystal display element using the same
JP5240207B2 (en) * 2008-01-25 2013-07-17 日産化学工業株式会社 Liquid crystal aligning agent and liquid crystal display element using the same
JP5315754B2 (en) 2008-03-31 2013-10-16 Jsr株式会社 Radiation sensitive resin composition

Also Published As

Publication number Publication date
WO2011078132A1 (en) 2011-06-30
CN102667594A (en) 2012-09-12
JP5614412B2 (en) 2014-10-29
KR101759753B1 (en) 2017-07-19
CN102667594B (en) 2015-02-18
TWI494374B (en) 2015-08-01
JPWO2011078132A1 (en) 2013-05-09
KR20120123284A (en) 2012-11-08

Similar Documents

Publication Publication Date Title
TWI638009B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5904121B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI477478B (en) Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent
TWI438226B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5382372B2 (en) Liquid crystal alignment treatment agent and liquid crystal display element using the same
TWI510519B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same
JP6152914B2 (en) Novel dicarboxylic acid anhydride and process for producing the same
TWI596158B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI564344B (en) A method for preparing a polyimide varnish, and a liquid crystal aligning agent
TW200944553A (en) Liquid-crystal alignment material and liquid-crystal display element
TWI520984B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
TW201211108A (en) Liquid crystal aligning agent, liquid crystal alignment film produced using same, and liquid crystal display element
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW201422677A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI494374B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same
WO2014024892A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI683857B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element